**Postnatal Neurogenesis in the Subventricular Zone: A Manipulable Source for CNS Plasticity and Repair**

Manavendra Pathania and Angelique Bordey

Additional information is available at the end of the chapter

http://dx.doi.org/10.5772/55679

#### **1. Introduction**

Neurogenesis is the production of new nerve cells or neurons, a specialized class of cells that make up the functional components of the central nervous system (CNS). Throughout most of the CNS this process of neurogenesis is limited to the developmental period before birth, after which time no new cells are added to the pre-established circuitry. In mammals including humans however, neurogenesis persists into the early postnatal period in two discrete brain regions: the subgranular zone in the hippocampus and the subventricular zone (SVZ) lining the lateral ventricles [1-5]. It is unknown why neurogenesis continues in such discrete locations yet is excluded from most other brain regions. A finite number of neurons is thought to afford us a stable set of circuitry that is able to accumulate and assimilate experiential information throughout our lifetimes. However, this predetermined number of neurons is also our Achilles' heel as any accidental or pathological damage to the CNS often results in irreparable damage to neurons. Consequently, there is a great unmet need for endogenous sources of brain repair, for conditions such as neurodegenerative disorders, cognitive neurological impairments, epilepsy, and cancer. This reason is one of the primary driving forces behind the study of postnatal neurogenesis and it is hoped that once the mechanisms are understood, this process can be harnessed to provide therapeutic avenues for intractable neuropathologies. Consider‐ able progress has been made in the last twenty years to unravel the mechanisms that both define and limit postnatal neurogenesis.

In this chapter we will limit our discussion to therapeutically relevant regulators of SVZ neurogenesis. We will first start with potentially manipulable intracellular and extracellular factors that have been found to control SVZ neurogenesis. Then, we will evaluate the signaling cascades downstream of neurotransmitter receptor activity that have also been shown to play

© 2013 Pathania and Bordey; licensee InTech. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. © 2013 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

regulatory roles within the SVZ. Finally, we will discuss the neuropathologies in which SVZ neurogenesis has been implicated.

tumorigenesis. To this end, cell-intrinsic factors comprise a major component of this regulation and help coordinate neurogenesis by forming the bulwark of how cells make choices and adapt to changes in their environments. Importantly, these intracellular factors may represent

Postnatal Neurogenesis in the Subventricular Zone: A Manipulable Source for CNS Plasticity and Repair

http://dx.doi.org/10.5772/55679

139

In the postnatal SVZ, progenitor fate commitment is sequentially driven by a family of proneural proteins called the basic helix-loop-helix (bHLH) transcription factors, such as Mash1/Ascl1, neurogenin2 (Ngn2), Neuro-D1, Neuro-D2, Tbr1 and Tbr2, in a pattern similar to cortical and hippocampal neurogenesis [24;25]. This bHLH-driven fate commitment is thought to develop in a temporally successive fashion, from more broadly proneural proteins (Mash1/Ascl1) to more neuronal and subtype-specifying (Neuro-D1) [26]. Although more work needs to be done to fully flesh out the role of bHLH proteins in the postnatal SVZ, *in vitro* transient expression of bHLH proteins is sufficient to induce neuronal fate commitment. Recently, a synthetic small molecule isoxazole 9 (Isx-9) has shown promise in enhancing hippocampal neurogenesis *in vivo*, by targeting a family of regulatory interactors of Mash1/ Ascl1, the myocyte-enhancer family (Mef2) [27]. This study heralds future therapies that can target and harness specific intracellular pathways within the neurogenic niche to direct

The bHLH proteins are thought to induce differentiation in part by activating cyclin-depend‐ ent kinase inhibitors that then induce cell cycle exit. This finding has been shown in culture and awaits confirmation *in vivo* [28]. Cdk inhibitors p27KIP1 and p19INK4d have also been shown to modulate proliferation in the SVZ. Mice lacking p27KIP1 show increased progenitor proliferation and a reduction in neuroblast number [29;30]. Furthermore, mice deficient for both p27KIP1 and p19INK4d display renewed proliferation of post-mitotic neurons and increased cell death- causing seizures, movement disorders, and death by postnatal day 18 [31]. This indicates that cdk inhibitors positively regulate cell cycle exit in SVZ progenitors and their absence prolongs or renews cell cycling. Cdk inhibitors mediate cell cycle exit by inhibiting phosphorylation of the retinoblastoma protein (Rb) [32]. Dephosphorylated Rb binds to and sequesters the E2F transcription factor that normally functions in the nucleus to positively regulate cell cycle progression, thereby promoting cell cycle exit. In the SVZ, E2Fdeficient mice show reduced progenitor proliferation and neuroblast numbers, suggesting that E2F transcriptional activity is required for cell cycle progression and the maintenance of neurogenic ability [33]. Additionally, mice lacking the gene encoding the tumor suppressor p53, another cell cycle regulator, displayed enhanced proliferative capacity and increased differentiation into neurons and oligodendrocytes [34]. Taken together, these results outline a stereotyped program of cell-intrinsic mechanisms at work within the SVZ to regulate the proliferation and fate commitment of SVZ progenitors in the early steps of postnatal neuro‐ genesis. The development of therapies that can target these pathways within neurogenic niches

MicroRNAs (miRs) are short, non-coding, single-stranded RNA molecules approximately 19-23 nucleotides in length that regulate gene expression by binding to complementary elements in the untranslated regions of target mRNAs and inhibiting protein synthesis. They exert epigenetic control either to maintain the status quo in a cell, (*i.e.* to maintain tissue

clinically tractable opportunities for the treatment of neuropathologies.

is the next step for endogenous sources of brain repair.

neurogenesis.

In the two neurogenic regions, resident pools of slow-dividing, astrocyte-like stem cells generate highly proliferative transit amplifying progenitors that then give rise to fate-com‐ mitted neuronal or glial precursors [1-4]. These precursors (called neuroblasts or glioblasts) then migrate to their final destinations and differentiate into postmitotic neurons, astrocytes and oligodendrocytes. In the case of neurogenesis, newborn neurons undergo additional maturation steps to develop an appropriate dendritic morphology, receive and form synapses, and survive an activity-dependent competitive process to integrate into the local circuitry [5]. Thus, neurogenesis may be broadly divided into two phases: an early phase that includes (a) stem cell proliferation, neuronal vs. glial fate commitment and migration; and a later phase that involves the (b) morphological and synaptic development and survival of newborn neurons. Throughout this chapter, astrocytic stem cells are defined as the self-renewing, multipotent cells present in the SVZ that express glial markers, including the glutamate aspartate transporter (GLAST), the intermediate filament proteins glial fibrillary acidic protein (GFAP) and nestin, and the carbohydrate Lewis X (Lex) [1;6]. Intermediate progenitors, also called transit amplifying progenitors, express epidermal growth factor receptor (EGFR) and mammalian achaete-scute homolog 1 (Ascl1/Mash1), while neuroblasts, or neuronal precur‐ sors, are defined by the presence of immature neuronal markers, including doublecortin (DCX) and βIII-tubulin (Tuj1) [7-10].

In the SVZ, astrocytic stem cells reside in-between the striatal parenchyma and the ependymal cell layer that lines the lateral ventricles [11]. These stem cells generate rapidly dividing transit amplifying progenitors, which give rise to neuroblasts that migrate by moving tangentially through the rostral migratory stream (RMS) and into the olfactory bulb (OB) [12-14]. During migration these proliferative cells travel in chains, and are ensheathed by specialized astrocytes [15]. In the OB the neuroblasts exit the RMS, change direction and migrate radially outward to differentiate into dopaminergic and GABAergic periglomerular and granule interneurons [16-20]. Granule cells form dendrodendritic reciprocal synapses with mitral and tufted neurons in the bulb and inhibit their activity to fine-tune their output, ultimately playing a role in olfactory discrimination and learning [21]. Periglomerular cells make one-way as well as reciprocal synapses with the apical dendrites of the mitral/tufted cells and the terminals of the olfactory nerves that converge into the glomeruli [20;22;23]. The progression from astrocytic stem cell to neuronal progenitor to synaptic integration requires tightly coordinated, complex regulation by a multitude of factors.

#### **2. Progenitor proliferation, fate commitment and migration in the SVZ**

#### **2.1. Intracellular factors**

SVZ neurogenesis is subject to tight regulation, confined to isolated microenvironments and sensitive to neuronal activity, stress, and aging. This control may be required to prevent network instability, maintain experience-driven memory and behavioral patterns, and prevent tumorigenesis. To this end, cell-intrinsic factors comprise a major component of this regulation and help coordinate neurogenesis by forming the bulwark of how cells make choices and adapt to changes in their environments. Importantly, these intracellular factors may represent clinically tractable opportunities for the treatment of neuropathologies.

regulatory roles within the SVZ. Finally, we will discuss the neuropathologies in which SVZ

In the two neurogenic regions, resident pools of slow-dividing, astrocyte-like stem cells generate highly proliferative transit amplifying progenitors that then give rise to fate-com‐ mitted neuronal or glial precursors [1-4]. These precursors (called neuroblasts or glioblasts) then migrate to their final destinations and differentiate into postmitotic neurons, astrocytes and oligodendrocytes. In the case of neurogenesis, newborn neurons undergo additional maturation steps to develop an appropriate dendritic morphology, receive and form synapses, and survive an activity-dependent competitive process to integrate into the local circuitry [5]. Thus, neurogenesis may be broadly divided into two phases: an early phase that includes (a) stem cell proliferation, neuronal vs. glial fate commitment and migration; and a later phase that involves the (b) morphological and synaptic development and survival of newborn neurons. Throughout this chapter, astrocytic stem cells are defined as the self-renewing, multipotent cells present in the SVZ that express glial markers, including the glutamate aspartate transporter (GLAST), the intermediate filament proteins glial fibrillary acidic protein (GFAP) and nestin, and the carbohydrate Lewis X (Lex) [1;6]. Intermediate progenitors, also called transit amplifying progenitors, express epidermal growth factor receptor (EGFR) and mammalian achaete-scute homolog 1 (Ascl1/Mash1), while neuroblasts, or neuronal precur‐ sors, are defined by the presence of immature neuronal markers, including doublecortin (DCX)

In the SVZ, astrocytic stem cells reside in-between the striatal parenchyma and the ependymal cell layer that lines the lateral ventricles [11]. These stem cells generate rapidly dividing transit amplifying progenitors, which give rise to neuroblasts that migrate by moving tangentially through the rostral migratory stream (RMS) and into the olfactory bulb (OB) [12-14]. During migration these proliferative cells travel in chains, and are ensheathed by specialized astrocytes [15]. In the OB the neuroblasts exit the RMS, change direction and migrate radially outward to differentiate into dopaminergic and GABAergic periglomerular and granule interneurons [16-20]. Granule cells form dendrodendritic reciprocal synapses with mitral and tufted neurons in the bulb and inhibit their activity to fine-tune their output, ultimately playing a role in olfactory discrimination and learning [21]. Periglomerular cells make one-way as well as reciprocal synapses with the apical dendrites of the mitral/tufted cells and the terminals of the olfactory nerves that converge into the glomeruli [20;22;23]. The progression from astrocytic stem cell to neuronal progenitor to synaptic integration requires tightly coordinated, complex

**2. Progenitor proliferation, fate commitment and migration in the SVZ**

SVZ neurogenesis is subject to tight regulation, confined to isolated microenvironments and sensitive to neuronal activity, stress, and aging. This control may be required to prevent network instability, maintain experience-driven memory and behavioral patterns, and prevent

neurogenesis has been implicated.

138 Neural Stem Cells - New Perspectives

and βIII-tubulin (Tuj1) [7-10].

regulation by a multitude of factors.

**2.1. Intracellular factors**

In the postnatal SVZ, progenitor fate commitment is sequentially driven by a family of proneural proteins called the basic helix-loop-helix (bHLH) transcription factors, such as Mash1/Ascl1, neurogenin2 (Ngn2), Neuro-D1, Neuro-D2, Tbr1 and Tbr2, in a pattern similar to cortical and hippocampal neurogenesis [24;25]. This bHLH-driven fate commitment is thought to develop in a temporally successive fashion, from more broadly proneural proteins (Mash1/Ascl1) to more neuronal and subtype-specifying (Neuro-D1) [26]. Although more work needs to be done to fully flesh out the role of bHLH proteins in the postnatal SVZ, *in vitro* transient expression of bHLH proteins is sufficient to induce neuronal fate commitment.

Recently, a synthetic small molecule isoxazole 9 (Isx-9) has shown promise in enhancing hippocampal neurogenesis *in vivo*, by targeting a family of regulatory interactors of Mash1/ Ascl1, the myocyte-enhancer family (Mef2) [27]. This study heralds future therapies that can target and harness specific intracellular pathways within the neurogenic niche to direct neurogenesis.

The bHLH proteins are thought to induce differentiation in part by activating cyclin-depend‐ ent kinase inhibitors that then induce cell cycle exit. This finding has been shown in culture and awaits confirmation *in vivo* [28]. Cdk inhibitors p27KIP1 and p19INK4d have also been shown to modulate proliferation in the SVZ. Mice lacking p27KIP1 show increased progenitor proliferation and a reduction in neuroblast number [29;30]. Furthermore, mice deficient for both p27KIP1 and p19INK4d display renewed proliferation of post-mitotic neurons and increased cell death- causing seizures, movement disorders, and death by postnatal day 18 [31]. This indicates that cdk inhibitors positively regulate cell cycle exit in SVZ progenitors and their absence prolongs or renews cell cycling. Cdk inhibitors mediate cell cycle exit by inhibiting phosphorylation of the retinoblastoma protein (Rb) [32]. Dephosphorylated Rb binds to and sequesters the E2F transcription factor that normally functions in the nucleus to positively regulate cell cycle progression, thereby promoting cell cycle exit. In the SVZ, E2Fdeficient mice show reduced progenitor proliferation and neuroblast numbers, suggesting that E2F transcriptional activity is required for cell cycle progression and the maintenance of neurogenic ability [33]. Additionally, mice lacking the gene encoding the tumor suppressor p53, another cell cycle regulator, displayed enhanced proliferative capacity and increased differentiation into neurons and oligodendrocytes [34]. Taken together, these results outline a stereotyped program of cell-intrinsic mechanisms at work within the SVZ to regulate the proliferation and fate commitment of SVZ progenitors in the early steps of postnatal neuro‐ genesis. The development of therapies that can target these pathways within neurogenic niches is the next step for endogenous sources of brain repair.

MicroRNAs (miRs) are short, non-coding, single-stranded RNA molecules approximately 19-23 nucleotides in length that regulate gene expression by binding to complementary elements in the untranslated regions of target mRNAs and inhibiting protein synthesis. They exert epigenetic control either to maintain the status quo in a cell, (*i.e.* to maintain tissue

#### identity), or they act in dynamic processes occurring within cells to refine and sharpen transitional states, (*i.e.* facilitating the switch in expression profile occurring at active synapses that were previously silent) [35-37]. Their role in shaping the temporal dynamics and pheno‐ typic outcome of gene regulatory networks means that the functions of particular miRs become especially resolvable in plastic processes like postnatal neurogenesis, and miRs have recently been implicated in regulating the fate commitment of SVZ progenitors [38]. Although as yet untested, one idea for how bHLH proteins are sequentially activated and repressed and the transitions from multipotent progenitor to post-mitotic neuron more sharply defined is the successive miR-mediated downregulation of targeted bHLH proteins. In the SVZ, micro‐ RNA-124 was shown to be upregulated upon neuronal differentiation in the SVZ, and overexpression increased the number of mature neurons at the cost of proliferative progenitors and neuroblasts, while knockdown decreased mature neuron production and increased the number of glia [38]. MiR-124 was shown to mediate these effects by antagonizing Sox9, a transcription factor that directs glial differentiation. MiR-124 has also been shown to target SCP1, a component of the REST/NRSF complex that represses neuronal genes in non-neuronal cells and PTBP1, a repressor of neuron-specific alternative splicing [39-42].

Apart from modulating proliferation, diffusible factors have also been shown to affect the initial establishment of the neurogenic niche itself, by influencing stem cell self-renewal and cell fate decisions. The factors that regulate such homeostatic effects within the niche may comprise a separate class of growth factors and unlike FGF-2, VEGF and IGF-I, are not circulating systemically in the bloodstream at appreciable levels nor produced in an acute, dynamically regulated manner. Based on this hypothesis, sonic hedgehog (Shh), Wnts, bone morphogenic proteins (BMPs) and Notch/Delta are extracellular factors possibly acting in a more local fashion. Sonic hedgehog signaling is required for establishing and maintaining the quiescent pool of stem cells in the postnatal SVZ. Ablating Smoothened, the transmembrane protein required for hedgehog signaling, specifically in the SVZ results in the depletion of stem cells and proliferative transit amplifying progenitors by postnatal day 8 and the depletion of neuroblasts by postnatal day 30 [53]. The Notch-DSL (Delta/Serrate/LAG-2) pathway is a very highly conserved cell-cell signaling system that acts through single-pass transmembrane proteins. Binding of Notch to its ligand causes cleavage of an intracellular domain that translocates to the nucleus where it interacts with transcriptional regulators to initiate expression of target genes like Hes1 and Hes5. In mammals, Notch ligands like Delta-like and Jagged bind Notch on stem and proliferative cells to maintain self-renewal and prevent terminal differentiation. In the neonatal SVZ, retrovirally delivered activated Notch enhances the numbers of quiescent SVZ progenitors at the cost of migratory neuroblasts [54]. Another study shows that conditional ablation of Notch signaling in the ependymal cells reprograms these cells and enables them to leave their position in the epithelium, take on SVZ stem cell characteristics and differentiate into granule and periglomerular neurons in the OB [55]. BMPs, a family of growth factors within the transforming growth factor β superfamily, have been shown to instruct a glial lineage in SVZ stem cells, and noggin, a BMP antagonist secreted by the adjacent ependymal cells, blocks glial differentiation of stem cells in favor of neurogenesis [56]. However, deletion of Smad4, a downstream target of BMP signaling, instead of increasing neurogenesis has been shown to result in oligodendrocyte production and a neurogenic deficit

Postnatal Neurogenesis in the Subventricular Zone: A Manipulable Source for CNS Plasticity and Repair

http://dx.doi.org/10.5772/55679

141

[57]. Therefore, it seems that BMP signaling can have divergent effects in the SVZ.

toward a more clinically oriented direction.

Exciting justification for these disparate lines of research is now beginning to emerge. Small molecule inhibitors of glycogen-synthase kinase 3 (GSK-3) inhibitors have shown promise in enhancing neurogenesis in human neural progenitor cells [58]. GSK-3 is involved in the notch, Shh, Wnt/β-catenin and FGF signaling pathways and represents a movement of the field

In the SVZ, neuroblasts have to migrate a greater distance than do their analogues in the dentate gyrus, to arrive at their ultimate destinations in the OB. Furthermore, the migration behavior exhibited by SVZ neuroblasts has two phases; it is tangential from the SVZ to the RMS-OB, and then becomes radial-like as the neuroblasts exit the RMS and begin synaptic integration into the granule cell layer. For our purposes in this review both phases of this migration are being considered within the "early" phase of neurogenesis, prior to dendritic arborization, reception of synaptic inputs, and survival. This feature of SVZ neurogenesis distinguishes it from hippocampal neurogenesis where the neuroblasts migrate very short distances, and has allowed for the isolation of a few important guidance molecules that enable

Together these results indicate that miR-124 is a critical regulator of neuronal development and tissue identity, acting early on in the shift from neuronal precursor to mature neuron. Synthetic miR anologues composed of locked nucleic acid technology (LNA) demonstrate a robust half-life and good tolerance in animal models and may prove a good strategy to induce neurogenesis in a therapeutic setting. Furthermore, transplantable cells stably expressing a complement of miRs may prove beneficial in cellular replacement strategies. Cell-intrinsic factors and their roles in the early phases of postnatal neurogenesis have only begun to become amenable to experimental dissection, and exciting developments are forthcoming.

#### **2.2. Extracellular factors**

Neurotrophic factors have long been implicated in the dynamic regulation of postnatal neurogenesis. In the SVZ, fibroblast growth factor 2 (FGF-2) has been shown to affect the early steps in neurogenesis, positively regulating progenitor proliferation and leading to an increase in the number of neurons migrating from the SVZ into the OB [43;44]. Furthermore, FGF-2 is known to interact with epidermal growth factor (EGF) receptor signaling in neuronal progen‐ itors, wherein prior FGF exposure is necessary for progenitors to respond to EGF or trans‐ forming growth factor β (TGFβ), the endogenous ligand for EGF receptors [45-49]. EGF has been shown to also increase proliferation specifically in the SVZ transit amplifying progenitor population at the cost of neuronal differentiation. Exposure to EGF induces transit amplifying progenitors to increase their cycling and downregulate neurogenic markers [50]. Vascular endothelial growth factor (VEGF), an angiogenic protein that can produce neurotrophic effects, has been shown to stimulate proliferation and neuroblast production in the SVZ, while insulinlike growth factor-I (IGF-I), a growth factor implicated in mediating the positive effects of exercise on adult neurogenesis, has been also implicated in enhancing proliferation and migration in the postnatal SVZ [51;52].

Apart from modulating proliferation, diffusible factors have also been shown to affect the initial establishment of the neurogenic niche itself, by influencing stem cell self-renewal and cell fate decisions. The factors that regulate such homeostatic effects within the niche may comprise a separate class of growth factors and unlike FGF-2, VEGF and IGF-I, are not circulating systemically in the bloodstream at appreciable levels nor produced in an acute, dynamically regulated manner. Based on this hypothesis, sonic hedgehog (Shh), Wnts, bone morphogenic proteins (BMPs) and Notch/Delta are extracellular factors possibly acting in a more local fashion. Sonic hedgehog signaling is required for establishing and maintaining the quiescent pool of stem cells in the postnatal SVZ. Ablating Smoothened, the transmembrane protein required for hedgehog signaling, specifically in the SVZ results in the depletion of stem cells and proliferative transit amplifying progenitors by postnatal day 8 and the depletion of neuroblasts by postnatal day 30 [53]. The Notch-DSL (Delta/Serrate/LAG-2) pathway is a very highly conserved cell-cell signaling system that acts through single-pass transmembrane proteins. Binding of Notch to its ligand causes cleavage of an intracellular domain that translocates to the nucleus where it interacts with transcriptional regulators to initiate expression of target genes like Hes1 and Hes5. In mammals, Notch ligands like Delta-like and Jagged bind Notch on stem and proliferative cells to maintain self-renewal and prevent terminal differentiation. In the neonatal SVZ, retrovirally delivered activated Notch enhances the numbers of quiescent SVZ progenitors at the cost of migratory neuroblasts [54]. Another study shows that conditional ablation of Notch signaling in the ependymal cells reprograms these cells and enables them to leave their position in the epithelium, take on SVZ stem cell characteristics and differentiate into granule and periglomerular neurons in the OB [55]. BMPs, a family of growth factors within the transforming growth factor β superfamily, have been shown to instruct a glial lineage in SVZ stem cells, and noggin, a BMP antagonist secreted by the adjacent ependymal cells, blocks glial differentiation of stem cells in favor of neurogenesis [56]. However, deletion of Smad4, a downstream target of BMP signaling, instead of increasing neurogenesis has been shown to result in oligodendrocyte production and a neurogenic deficit [57]. Therefore, it seems that BMP signaling can have divergent effects in the SVZ.

identity), or they act in dynamic processes occurring within cells to refine and sharpen transitional states, (*i.e.* facilitating the switch in expression profile occurring at active synapses that were previously silent) [35-37]. Their role in shaping the temporal dynamics and pheno‐ typic outcome of gene regulatory networks means that the functions of particular miRs become especially resolvable in plastic processes like postnatal neurogenesis, and miRs have recently been implicated in regulating the fate commitment of SVZ progenitors [38]. Although as yet untested, one idea for how bHLH proteins are sequentially activated and repressed and the transitions from multipotent progenitor to post-mitotic neuron more sharply defined is the successive miR-mediated downregulation of targeted bHLH proteins. In the SVZ, micro‐ RNA-124 was shown to be upregulated upon neuronal differentiation in the SVZ, and overexpression increased the number of mature neurons at the cost of proliferative progenitors and neuroblasts, while knockdown decreased mature neuron production and increased the number of glia [38]. MiR-124 was shown to mediate these effects by antagonizing Sox9, a transcription factor that directs glial differentiation. MiR-124 has also been shown to target SCP1, a component of the REST/NRSF complex that represses neuronal genes in non-neuronal

cells and PTBP1, a repressor of neuron-specific alternative splicing [39-42].

amenable to experimental dissection, and exciting developments are forthcoming.

**2.2. Extracellular factors**

140 Neural Stem Cells - New Perspectives

migration in the postnatal SVZ [51;52].

Together these results indicate that miR-124 is a critical regulator of neuronal development and tissue identity, acting early on in the shift from neuronal precursor to mature neuron. Synthetic miR anologues composed of locked nucleic acid technology (LNA) demonstrate a robust half-life and good tolerance in animal models and may prove a good strategy to induce neurogenesis in a therapeutic setting. Furthermore, transplantable cells stably expressing a complement of miRs may prove beneficial in cellular replacement strategies. Cell-intrinsic factors and their roles in the early phases of postnatal neurogenesis have only begun to become

Neurotrophic factors have long been implicated in the dynamic regulation of postnatal neurogenesis. In the SVZ, fibroblast growth factor 2 (FGF-2) has been shown to affect the early steps in neurogenesis, positively regulating progenitor proliferation and leading to an increase in the number of neurons migrating from the SVZ into the OB [43;44]. Furthermore, FGF-2 is known to interact with epidermal growth factor (EGF) receptor signaling in neuronal progen‐ itors, wherein prior FGF exposure is necessary for progenitors to respond to EGF or trans‐ forming growth factor β (TGFβ), the endogenous ligand for EGF receptors [45-49]. EGF has been shown to also increase proliferation specifically in the SVZ transit amplifying progenitor population at the cost of neuronal differentiation. Exposure to EGF induces transit amplifying progenitors to increase their cycling and downregulate neurogenic markers [50]. Vascular endothelial growth factor (VEGF), an angiogenic protein that can produce neurotrophic effects, has been shown to stimulate proliferation and neuroblast production in the SVZ, while insulinlike growth factor-I (IGF-I), a growth factor implicated in mediating the positive effects of exercise on adult neurogenesis, has been also implicated in enhancing proliferation and

Exciting justification for these disparate lines of research is now beginning to emerge. Small molecule inhibitors of glycogen-synthase kinase 3 (GSK-3) inhibitors have shown promise in enhancing neurogenesis in human neural progenitor cells [58]. GSK-3 is involved in the notch, Shh, Wnt/β-catenin and FGF signaling pathways and represents a movement of the field toward a more clinically oriented direction.

In the SVZ, neuroblasts have to migrate a greater distance than do their analogues in the dentate gyrus, to arrive at their ultimate destinations in the OB. Furthermore, the migration behavior exhibited by SVZ neuroblasts has two phases; it is tangential from the SVZ to the RMS-OB, and then becomes radial-like as the neuroblasts exit the RMS and begin synaptic integration into the granule cell layer. For our purposes in this review both phases of this migration are being considered within the "early" phase of neurogenesis, prior to dendritic arborization, reception of synaptic inputs, and survival. This feature of SVZ neurogenesis distinguishes it from hippocampal neurogenesis where the neuroblasts migrate very short distances, and has allowed for the isolation of a few important guidance molecules that enable this directed migration. Slit-1 and Slit-2 expression in the SVZ and septum is thought to repel neuroblasts away from the SVZ and towards the OB, while netrin expression in the mitral cells of the OB, and the coincident expression of netrin receptors neogenin and deleted in colorectal cancer (DCC) in neuroblasts may form a chemoattractive cue drawing neuroblasts towards the OB [59-61]. The secreted protein prokineticin2 (PK2) has also been shown to act as potent chemoattractant for SVZ neuronal progenitors. PK2 is expressed in the OB, and attracts SVZ cells to the OB through the two G-protein coupled prokineticin receptors (PRK1 and PRK2] [62]. Both ephrins and their Eph tyrosine kinase receptors are expressed in the SVZ and have been shown to play a role in both regulation of progenitor proliferation and neuroblast migration. EphA7, EphB2 and ephrin-B2 are associated with astrocytic progenitors in the SVZ, while ephrin-A2 is expressed in the neuroblasts. Ephrin-B2 and EphB2 signaling seem to positively regulate progenitor proliferation while also disrupting neuroblast migration in the postnatal SVZ, while ephrin-A2 seemed to positively regulate progenitor proliferation [63;64]. Tangential migration in the RMS has also been shown to involve the α6β1 integrin [65]. Once in the OB, neuroblasts have to reorient from tangential to radial migration into the GCL. This process has been shown to involve the expression of tenascin-R, in both the GCL and internal plexiform layers of the OB, and reelin, expressed by the mitral cells [66-68].

**2.4. GABA**

of the Cl-

GABA, a major inhibitory neurotransmitter in the mature CNS, has a well-established role in the development of neuronal circuits in both the embryo and adult [8;75-77]. Its ambient release in the form of spillover from synaptic and extra-synaptic sources has led researchers to its role in regulating the functional integration of new neurons into both immature and mature

Postnatal Neurogenesis in the Subventricular Zone: A Manipulable Source for CNS Plasticity and Repair

GABA, acting through GABAA receptors, to depolarize immature cells in the first few weeks after fate determination. The depolarizing effect of GABA on young neurons and progenitors has been shown to regulate key stages of neurogenesis such as proliferation, migration and

Adult neurogenesis in the SVZ recapitulates the embryonic role for GABA [8;81;82]. In the SVZ, both astrocytic stem cells and their neuroblast progeny express GABAA receptors [5;83]. Electrophysiological evidence indicates that neuroblasts release GABA in a non-synaptic and non-vesicular fashion, and that this tonically activates GABAA receptors on SVZ astrocytic stem cells [84;85]. The SVZ astrocytes also express GABA transporters that may further regulate levels of ambient GABA within the niche. Pharmacological inhibition of GABAA receptors in SVZ slice-culture preparations increases mitotic activity within the SVZ [85;86]. Blocking GABA transporters or enhancing GABA release from neuroblasts on the other hand, slows the speed of their own migration, in a paracrine/autocrine fashion in the SVZ and RMS [87]. Furthermore, knocking down Na-K-2Cl cotransporter NKCC1 and thereby reducing GABA(A)-induced depolarization in the SVZ reduced proliferation, migration as well dendrite development [79;80]. These data together suggest that GABA has a role as a negative regulator of early stages of neurogenesis in the SVZ, where it reduces neuroblasts and SVZ astrocyte proliferation and decreases the speed of neuroblast migration. This is analogous to the role of GABAA activation in the developing cortex, where it also serves to limit proliferation of

importer NKCC1 and the low expression

in neuroblasts causes

http://dx.doi.org/10.5772/55679

143

concentrations are higher in immature neurons than

networks. Owing to the initial abundance of the Cl-

mature neurons [76]. The resultant high equilibrium potential for Cl-

morphogenesis, in both the embryonic and adult neurogenic zones [78-80].

ventricular zone progenitors and migration of postmitotic neuroblasts [88-90].

metabolic activity may loop back onto the SVZ and SGZ.

**2.5. Glutamate**

GABA's role in regulating early phases of neurogenesis such as proliferation and migration has been examined more extensively in the SVZ where it has been shown to act as a negative regulator of early neurogenesis. Whether these effects are corroborated in the SGZ is as yet unknown. An attractive hypothesis explaining GABA's disparate roles in development, postnatal neurogenesis, and at the synapse is that neurotransmitter-based signaling may serve as a bridge that brings an activity-dependence to cell-autonomous and locally present instructive signals that drive neurogenesis and network plasticity. In this way, neuronal and

During embryonic neurogenesis, glutamate signaling has been shown to influence prolifera‐ tion, fate commitment, and migration of newborn neurons [88;89;91-93]. During postnatal neurogenesis, in the SVZ neuroblasts have been shown to express functional NMDA receptors as well as functional mGluR5 and GLUk5-containing kainate receptors, using both electro‐

exporter KCC2, internal Cl-

There is now a large amount of information regarding the effects of neurotrophic factors on early stages of SVZ neurogenesis, all of which is not discussed here. Many exciting avenues are emerging for therapeutic intervention into neurodegenerative diseases and psychiatric illnesses and knowledge of how neurogenic niches are formed, maintained, and neuronal and glial programs directed is fundamental for devising a clinical paradigm of directed neurogen‐ esis. However, these data on extracellular factor-based modulation of postnatal neurogenesis needs more critical validation within the context of *in vivo* experiments and behavioral analyses.

#### **2.3. Dopamine**

The SVZis innervatedbydopaminergic fibers originating inthe substantianigra, while the SGZ is innervated by dopaminergic fibers coming from the ventral tegmental area (VTA). Dopami‐ nergic signaling has been shown to regulate progenitor proliferation through D2 receptors in boththe SVZandSGZandD3 receptors inthe SVZ[69-71].InpatientswithParkinson'sDisease, SVZproliferationismarkedlyreduced.Thiseffectonproliferationhasbeenshowntobemediated through the induction of EGF and CNTF secretion from SVZ stem cells in response to dopami‐ nergic activity [72;73].Dopaminergicdeafferentiationreducesproliferationin the SVZ, andone study reports that this decrease in overall SVZ cell proliferation is nonetheless accompanied by an increase in numbers of cells expressing Pax6 in the dorsal SVZ. Pax6 is a transcription factor responsible for enabling a dopaminergic differentiation program in postnatally generated periglomerular neurons. Therefore, dopaminergic activity may not only affect proliferation but may also impact cell fate choice in the SVZ [74]. Drugs that potentiate dopamingergic signal‐ ing may represent one strategy to maintain neurongenesis postnatally. Dopaminergic regula‐ tion of postnatal neurogenesis is only beginning to be uncovered, and its role in neurogenesis has not been conclusively established as yet.

#### **2.4. GABA**

this directed migration. Slit-1 and Slit-2 expression in the SVZ and septum is thought to repel neuroblasts away from the SVZ and towards the OB, while netrin expression in the mitral cells of the OB, and the coincident expression of netrin receptors neogenin and deleted in colorectal cancer (DCC) in neuroblasts may form a chemoattractive cue drawing neuroblasts towards the OB [59-61]. The secreted protein prokineticin2 (PK2) has also been shown to act as potent chemoattractant for SVZ neuronal progenitors. PK2 is expressed in the OB, and attracts SVZ cells to the OB through the two G-protein coupled prokineticin receptors (PRK1 and PRK2] [62]. Both ephrins and their Eph tyrosine kinase receptors are expressed in the SVZ and have been shown to play a role in both regulation of progenitor proliferation and neuroblast migration. EphA7, EphB2 and ephrin-B2 are associated with astrocytic progenitors in the SVZ, while ephrin-A2 is expressed in the neuroblasts. Ephrin-B2 and EphB2 signaling seem to positively regulate progenitor proliferation while also disrupting neuroblast migration in the postnatal SVZ, while ephrin-A2 seemed to positively regulate progenitor proliferation [63;64]. Tangential migration in the RMS has also been shown to involve the α6β1 integrin [65]. Once in the OB, neuroblasts have to reorient from tangential to radial migration into the GCL. This process has been shown to involve the expression of tenascin-R, in both the GCL and internal

plexiform layers of the OB, and reelin, expressed by the mitral cells [66-68].

analyses.

**2.3. Dopamine**

142 Neural Stem Cells - New Perspectives

has not been conclusively established as yet.

There is now a large amount of information regarding the effects of neurotrophic factors on early stages of SVZ neurogenesis, all of which is not discussed here. Many exciting avenues are emerging for therapeutic intervention into neurodegenerative diseases and psychiatric illnesses and knowledge of how neurogenic niches are formed, maintained, and neuronal and glial programs directed is fundamental for devising a clinical paradigm of directed neurogen‐ esis. However, these data on extracellular factor-based modulation of postnatal neurogenesis needs more critical validation within the context of *in vivo* experiments and behavioral

The SVZis innervatedbydopaminergic fibers originating inthe substantianigra, while the SGZ is innervated by dopaminergic fibers coming from the ventral tegmental area (VTA). Dopami‐ nergic signaling has been shown to regulate progenitor proliferation through D2 receptors in boththe SVZandSGZandD3 receptors inthe SVZ[69-71].InpatientswithParkinson'sDisease, SVZproliferationismarkedlyreduced.Thiseffectonproliferationhasbeenshowntobemediated through the induction of EGF and CNTF secretion from SVZ stem cells in response to dopami‐ nergic activity [72;73].Dopaminergicdeafferentiationreducesproliferationin the SVZ, andone study reports that this decrease in overall SVZ cell proliferation is nonetheless accompanied by an increase in numbers of cells expressing Pax6 in the dorsal SVZ. Pax6 is a transcription factor responsible for enabling a dopaminergic differentiation program in postnatally generated periglomerular neurons. Therefore, dopaminergic activity may not only affect proliferation but may also impact cell fate choice in the SVZ [74]. Drugs that potentiate dopamingergic signal‐ ing may represent one strategy to maintain neurongenesis postnatally. Dopaminergic regula‐ tion of postnatal neurogenesis is only beginning to be uncovered, and its role in neurogenesis GABA, a major inhibitory neurotransmitter in the mature CNS, has a well-established role in the development of neuronal circuits in both the embryo and adult [8;75-77]. Its ambient release in the form of spillover from synaptic and extra-synaptic sources has led researchers to its role in regulating the functional integration of new neurons into both immature and mature networks. Owing to the initial abundance of the Cl importer NKCC1 and the low expression of the Cl exporter KCC2, internal Cl concentrations are higher in immature neurons than mature neurons [76]. The resultant high equilibrium potential for Cl in neuroblasts causes GABA, acting through GABAA receptors, to depolarize immature cells in the first few weeks after fate determination. The depolarizing effect of GABA on young neurons and progenitors has been shown to regulate key stages of neurogenesis such as proliferation, migration and morphogenesis, in both the embryonic and adult neurogenic zones [78-80].

Adult neurogenesis in the SVZ recapitulates the embryonic role for GABA [8;81;82]. In the SVZ, both astrocytic stem cells and their neuroblast progeny express GABAA receptors [5;83]. Electrophysiological evidence indicates that neuroblasts release GABA in a non-synaptic and non-vesicular fashion, and that this tonically activates GABAA receptors on SVZ astrocytic stem cells [84;85]. The SVZ astrocytes also express GABA transporters that may further regulate levels of ambient GABA within the niche. Pharmacological inhibition of GABAA receptors in SVZ slice-culture preparations increases mitotic activity within the SVZ [85;86]. Blocking GABA transporters or enhancing GABA release from neuroblasts on the other hand, slows the speed of their own migration, in a paracrine/autocrine fashion in the SVZ and RMS [87]. Furthermore, knocking down Na-K-2Cl cotransporter NKCC1 and thereby reducing GABA(A)-induced depolarization in the SVZ reduced proliferation, migration as well dendrite development [79;80]. These data together suggest that GABA has a role as a negative regulator of early stages of neurogenesis in the SVZ, where it reduces neuroblasts and SVZ astrocyte proliferation and decreases the speed of neuroblast migration. This is analogous to the role of GABAA activation in the developing cortex, where it also serves to limit proliferation of ventricular zone progenitors and migration of postmitotic neuroblasts [88-90].

GABA's role in regulating early phases of neurogenesis such as proliferation and migration has been examined more extensively in the SVZ where it has been shown to act as a negative regulator of early neurogenesis. Whether these effects are corroborated in the SGZ is as yet unknown. An attractive hypothesis explaining GABA's disparate roles in development, postnatal neurogenesis, and at the synapse is that neurotransmitter-based signaling may serve as a bridge that brings an activity-dependence to cell-autonomous and locally present instructive signals that drive neurogenesis and network plasticity. In this way, neuronal and metabolic activity may loop back onto the SVZ and SGZ.

#### **2.5. Glutamate**

During embryonic neurogenesis, glutamate signaling has been shown to influence prolifera‐ tion, fate commitment, and migration of newborn neurons [88;89;91-93]. During postnatal neurogenesis, in the SVZ neuroblasts have been shown to express functional NMDA receptors as well as functional mGluR5 and GLUk5-containing kainate receptors, using both electro‐ physiology and calcium imaging [94;95]. Evidence from our lab suggests glutamate released spontaneously from SVZ-RMS astrocytes generates phasic NMDA receptor activity in neuroblasts migrating towards the OB [96]. Both mGluR5 and GLUk5 activation have also been shown to mediate increases in intracellular Ca2+ transients in SVZ neuroblasts [95;97]. A mosaic of GABAA, NMDA, mGluR5, and GLUk5 (now known as GluK2) receptor-expressing cells reside in the SVZ, where most cells express GABAA receptors in caudal SVZ and moving rostrally, a greater proportion of cells begin to express a combination of receptors. Ultimately, nearly half of all cells in the rostral RMS express all four types of receptors, indicating the continuing maturation of newborn cells along the SVZ-OB neurogenic axis. Mice lacking mGluR5, or in which mGluR5 was pharmacologically blocked, displayed a marked decrease in the number of proliferating cells in the SVZ [98]. This indicates a role for glutamate -acting tonically through metabotropic receptors- in positively regulating SVZ progenitor prolifera‐ tion and antagonizing tonic GABAA-ergic receptor-induced anti-mitotic activity; perhaps acting as a positive regulator of early neurogenic processes. Blocking GLUk5 in the RMS on the other hand, increased the speed of neuroblast migration, suggesting that tonic GLUk5-mediated glutamatergic transmission decreases neuroblast clearance from the SVZ and acts in concert with GABA's effect on migration in the SVZ [97]. mGluR5 activity however, does not influence migration speed. It could be that GLUk5-mediated signaling activated different Ca2+-dependent intracellular cascades than mGluR5 signaling. It remains to be seen whether AMPA/kainate or NMDA receptor activity can have a positive effect on migration in the SVZ/RMS. These data together suggest that although glutamate receptor heterogeneity and the multiple intracellular pathways they may activate introduce ambiguity into what role glutamate may play in early neurogenesis in the SVZ, metabotropic glutamate receptor signaling enhances proliferation, while AMPA/kainate receptor signaling acts together with GABA to decrease migration of neuroblasts. More work is needed to fully flesh out the roles that the three different glutamate receptor families (NMDA, mGluR and AMPA/kainate) have in the SVZ. Work also is needed to elucidate how glutamate receptor heterogeneity parses among the different SVZ sublineages (Emx-1, Gsh2, Nkx2.1).

is a long-studied transcription factor known for underlying the later stages of synaptic plasticity and memory formation, as well as for linking neuronal activity to survival. In the postnatal SVZ-OB, CREB has been shown to be important in the survival and dendritic arborization of SVZ neuroblasts [99]. CREB phosphorylation is transient and parallels maturation, increasing during migration towards the OB and decreasing once radial migration and synaptic integration are completed. CREB-deficient mice show deficits in neuroblast survival in the OB, and CREB inhibition *in vitro* severely attenuates neurite outgrowth, suggesting that CREB positively modulates survival and dendritic elaboration in the OB and plays an important role in the later phases of SVZ neurogenesis. Data from our lab and others suggests that a CREB-regulated microRNA, miR-132, is involved in mediating some of the effects seen by impairing CREB activity in the SVZ. miR-132 expression is upregulated along the migratory route of the SVZ neuroblasts, peaking in the OB, and miR-132 overexpression enhances morphological complexity, spine density and survival of newborn neurons *in vivo* [100]. These data suggest that CREB and a CREB-regulated miRNA may form the basis of a structural plasticity program seen in SVZ postnatal neurogenesis. Intrinsic mechanisms regulating later stages of neurogenesis are some of the least elaborated aspects of postnatal neurogenesis. Additionally, with the emergence of inducible and conditional manipulation techniques, it has become possible to discretely assay the roles of many factors within the context of postnatal neurogenesis. Work is also emerging that utilizes the stop-flox-mediated overexpression of factors in a conditional and inducible manner. MiR-132 and other recently identified miRs that promote synapse maintenance because of their ease of delivery represent therapeutic strategies for the stable maintenance of newly generated neurons in disease states.

Postnatal Neurogenesis in the Subventricular Zone: A Manipulable Source for CNS Plasticity and Repair

http://dx.doi.org/10.5772/55679

145

Later stages of postnatal neurogenesis have also been shown to be responsive to neurotrophic factor signaling. A single nucleotide polymorphism in the human brain derived neurotrophic factor (BDNF)-encoding gene (Val66Met) has been shown to correlate with mood disorders and memory deficits, and knock-in mice possessing the human SNP showed reduced activitydependent BDNF secretion ultimately resulting in reduced survival of SVZ neuroblasts and impaired spontaneous olfactory discrimination [101]. In this study, activity-dependent BDNF signaling in the SVZ was shown to exert its effects on survival and olfactory function through TrkB receptors on neuroblasts. BDNF signaling and Trk receptor activity have been widely shown to have neurotrophic and synapse-potentiating effects in neurons and may represent a general strategy to promote the survival and maintenance of newly generated neurons.

Later stages of neurogenesis are poorly studied in the SVZ. Knowledge of molecules regulat‐ ing the survival, synaptic integration and morphogenesis of newborn cells is more limited in comparison to the literature covering the DG. However, BDNF-signaling is an example of emerging data within the field that unites hypotheses between the two neurogenic niches. It is also interesting to note the sustained differences between the two niche microenvironments. NT-3-signaling is exclusive to the DG and may promote excitatory versus inhibitory neurogen‐ ic potential. It has also been suggested that the convergence of dopaminergic and serotonergic fibers defines the SVZ, while convergence of noradrenergic and serotonergic projections may

**3.2. Extracellular factors**

define the SGZ [68].

The diversity of glutamate receptors, the myriad intracellular pathways that they may activate and the many mechanisms by which levels of ambient glutamate are regulated suggests that glutamate, despite being nearly ubiquitously present, can have very specific and differential effects on SVZ cells. The data so far suggests glutamate may regulate the early phases of neurogenesis in manner that reflects this complexity. However, further work will involve clarifying some of the associated ambiguity surrounding glutamate availability, the receptor complement, the different intracellular pathways, and their effects on neurogenesis.

#### **3. Morphogenesis, synaptogenesis and circuit integration in the OB**

#### **3.1. Intracellular factors**

Later stages of neurogenesis include the survival, synaptic integration and dendritic elabora‐ tion of neuronal precursors within their target sites. CREB (cAMP response element binding) is a long-studied transcription factor known for underlying the later stages of synaptic plasticity and memory formation, as well as for linking neuronal activity to survival. In the postnatal SVZ-OB, CREB has been shown to be important in the survival and dendritic arborization of SVZ neuroblasts [99]. CREB phosphorylation is transient and parallels maturation, increasing during migration towards the OB and decreasing once radial migration and synaptic integration are completed. CREB-deficient mice show deficits in neuroblast survival in the OB, and CREB inhibition *in vitro* severely attenuates neurite outgrowth, suggesting that CREB positively modulates survival and dendritic elaboration in the OB and plays an important role in the later phases of SVZ neurogenesis. Data from our lab and others suggests that a CREB-regulated microRNA, miR-132, is involved in mediating some of the effects seen by impairing CREB activity in the SVZ. miR-132 expression is upregulated along the migratory route of the SVZ neuroblasts, peaking in the OB, and miR-132 overexpression enhances morphological complexity, spine density and survival of newborn neurons *in vivo* [100]. These data suggest that CREB and a CREB-regulated miRNA may form the basis of a structural plasticity program seen in SVZ postnatal neurogenesis. Intrinsic mechanisms regulating later stages of neurogenesis are some of the least elaborated aspects of postnatal neurogenesis. Additionally, with the emergence of inducible and conditional manipulation techniques, it has become possible to discretely assay the roles of many factors within the context of postnatal neurogenesis. Work is also emerging that utilizes the stop-flox-mediated overexpression of factors in a conditional and inducible manner. MiR-132 and other recently identified miRs that promote synapse maintenance because of their ease of delivery represent therapeutic strategies for the stable maintenance of newly generated neurons in disease states.

#### **3.2. Extracellular factors**

physiology and calcium imaging [94;95]. Evidence from our lab suggests glutamate released spontaneously from SVZ-RMS astrocytes generates phasic NMDA receptor activity in neuroblasts migrating towards the OB [96]. Both mGluR5 and GLUk5 activation have also been shown to mediate increases in intracellular Ca2+ transients in SVZ neuroblasts [95;97]. A mosaic of GABAA, NMDA, mGluR5, and GLUk5 (now known as GluK2) receptor-expressing cells reside in the SVZ, where most cells express GABAA receptors in caudal SVZ and moving rostrally, a greater proportion of cells begin to express a combination of receptors. Ultimately, nearly half of all cells in the rostral RMS express all four types of receptors, indicating the continuing maturation of newborn cells along the SVZ-OB neurogenic axis. Mice lacking mGluR5, or in which mGluR5 was pharmacologically blocked, displayed a marked decrease in the number of proliferating cells in the SVZ [98]. This indicates a role for glutamate -acting tonically through metabotropic receptors- in positively regulating SVZ progenitor prolifera‐ tion and antagonizing tonic GABAA-ergic receptor-induced anti-mitotic activity; perhaps acting as a positive regulator of early neurogenic processes. Blocking GLUk5 in the RMS on the other hand, increased the speed of neuroblast migration, suggesting that tonic GLUk5-mediated glutamatergic transmission decreases neuroblast clearance from the SVZ and acts in concert with GABA's effect on migration in the SVZ [97]. mGluR5 activity however, does not influence migration speed. It could be that GLUk5-mediated signaling activated different Ca2+-dependent intracellular cascades than mGluR5 signaling. It remains to be seen whether AMPA/kainate or NMDA receptor activity can have a positive effect on migration in the SVZ/RMS. These data together suggest that although glutamate receptor heterogeneity and the multiple intracellular pathways they may activate introduce ambiguity into what role glutamate may play in early neurogenesis in the SVZ, metabotropic glutamate receptor signaling enhances proliferation, while AMPA/kainate receptor signaling acts together with GABA to decrease migration of neuroblasts. More work is needed to fully flesh out the roles that the three different glutamate receptor families (NMDA, mGluR and AMPA/kainate) have in the SVZ. Work also is needed to elucidate how glutamate receptor heterogeneity parses among the different SVZ sublineages

The diversity of glutamate receptors, the myriad intracellular pathways that they may activate and the many mechanisms by which levels of ambient glutamate are regulated suggests that glutamate, despite being nearly ubiquitously present, can have very specific and differential effects on SVZ cells. The data so far suggests glutamate may regulate the early phases of neurogenesis in manner that reflects this complexity. However, further work will involve clarifying some of the associated ambiguity surrounding glutamate availability, the receptor

complement, the different intracellular pathways, and their effects on neurogenesis.

**3. Morphogenesis, synaptogenesis and circuit integration in the OB**

Later stages of neurogenesis include the survival, synaptic integration and dendritic elabora‐ tion of neuronal precursors within their target sites. CREB (cAMP response element binding)

(Emx-1, Gsh2, Nkx2.1).

144 Neural Stem Cells - New Perspectives

**3.1. Intracellular factors**

Later stages of postnatal neurogenesis have also been shown to be responsive to neurotrophic factor signaling. A single nucleotide polymorphism in the human brain derived neurotrophic factor (BDNF)-encoding gene (Val66Met) has been shown to correlate with mood disorders and memory deficits, and knock-in mice possessing the human SNP showed reduced activitydependent BDNF secretion ultimately resulting in reduced survival of SVZ neuroblasts and impaired spontaneous olfactory discrimination [101]. In this study, activity-dependent BDNF signaling in the SVZ was shown to exert its effects on survival and olfactory function through TrkB receptors on neuroblasts. BDNF signaling and Trk receptor activity have been widely shown to have neurotrophic and synapse-potentiating effects in neurons and may represent a general strategy to promote the survival and maintenance of newly generated neurons.

Later stages of neurogenesis are poorly studied in the SVZ. Knowledge of molecules regulat‐ ing the survival, synaptic integration and morphogenesis of newborn cells is more limited in comparison to the literature covering the DG. However, BDNF-signaling is an example of emerging data within the field that unites hypotheses between the two neurogenic niches. It is also interesting to note the sustained differences between the two niche microenvironments. NT-3-signaling is exclusive to the DG and may promote excitatory versus inhibitory neurogen‐ ic potential. It has also been suggested that the convergence of dopaminergic and serotonergic fibers defines the SVZ, while convergence of noradrenergic and serotonergic projections may define the SGZ [68].

#### **3.3. GABA**

GABA-mediated depolarization of immature neurons has been shown to be critical for synapse formation in the developing cortex [102]. Postnatally, following migration into the OB SVZ neuroblasts begin the process of integrating into the local circuitry by radially migrating out of the RMS core, elaborating a complex dendritic structure and establishing appropriate synapses [5;103]. A role for GABAA signaling in the initiation, elongation and stabilization of dendritic structures in immature neurons has been established in the OB. Specifically, it was discovered that ambient GABA-induced depolarization and Ca2+-influx was necessary for the stabilization of emerging dendritic protrusions and enhanced the number and length of preexisting dendrites, in SVZ culture as well as OB slice preparations [104]. This effect was specific to the immature neuron population because six days following plating, KCC2 levels had increased sufficiently to block the depolarizing effects of GABA and the modulatory effects of GABA-depolarization on dendrite development. Furthermore, GABA activity promoted initiation and elongation of immature neuroblast dendrites in culture by stabilizing tubulin in its polymerized form. Knockdown of NKCC1 and prevention of GABA-mediated depolari‐ zation in immature neurons also resulted in dendritic morphological deficits. However, this effect was transient and dendritiric morphology recovered in adults [80].

**4. Responsiveness and involvement of postnatal neurogenesis in distinct**

Postnatal Neurogenesis in the Subventricular Zone: A Manipulable Source for CNS Plasticity and Repair

Alzheimer's disease (AD) is a late-onset neurological disease with a heritable component characterized by deposition of β-amyloid peptides (Aβ), formation of neurofibrillary tangles, reactive astrocytosis, activation of microglial cells and cholinergic deficits [108]. The effect of AD is a progressive neurodegeneration throughout the neocortex and hippocampus, and severe dementia [109]. SVZ neurogenesis is reduced in mouse models of AD and has also been shown to be diminished in postmortem tissue from human AD patients. Mice harboring familial mutations in amyloid precursor protein (APP) and presinilin 1 (PS1) show decreased proliferation in the SVZ [110;111]. Infusion of Aβ peptide into the lateral ventricles also decreases proliferation in the postnatal SVZ [112]. SVZ-derived neural progenitor cells from PS1 mutants and the APPSwe/PS1ΔE9 double-mutants showed decreased cycling *in vitro* [112; 113]. In postmortem tissue, AD patients showed decreased numbers of proliferative (Ki67<sup>+</sup>

cells in the SVZ [114]. Anosmia or hyposmia, the inability or reduced ability to perceive smell, are predictive indicators of Alzheimer's progression in the clinic. However, it remains to be conclusively established whether altered SVZ neurogenesis is the cause of this disrupted

Parkinson's disease (PD) develops due to the specific loss of dopaminergic neurons in the substantia nigra (SN) and results in impaired regulation of movement, mood, and motivation [69]. In mouse models of PD SVZ proliferation is reduced. This is thought to be due to the loss of dopaminergic inputs to the SVZ from the SN via the nigrostriatal pathway, as chemical ablation of these fibers results in decreased proliferation in the SVZ and decreased numbers of mature granule neurons in the OB [69;74]. This effect on proliferation was partially rescued with the application of the dopamine precursor levodopa. Furthermore, in postmortem tissue from human AD patients SVZ proliferation was reduced, as were numbers of immature neurons in the granule cell layer of the OB [69]. However, increases in numbers of periglo‐ merular dopaminergic neurons have also been reported in mouse models of PD using chemical ablation, and in PD postmortem human tissue [74;115]. Because dopaminergic activity of periglomerular cells generally inhibits the transmission of olfactory information, it is thought that the decreased numbers of granule cells and the increased numbers of periglomerular cells

together contribute to the hyposmia and disturbed olfaction seen in PD patients.

Huntington's disease (HD) is caused by expansions in CAG repeat elements in the gene encoding huntingin. This leads to aggregation of mutant huntingtin and neurodegeneration in the striatum [116]. In mouse models of HD there is little striatal neurodegeneration and consequently SVZ neurogenesis remains unchanged. However, in rat models of striatal

)

147

http://dx.doi.org/10.5772/55679

**neuropathologies**

**4.1. Alzheimer's disease**

olfaction in AD patients.

**4.2. Parkinson's disease**

**4.3. Huntington's disease**

This regulation by GABA in both the OB and DG helps shape neurogenesis as an activitydependent process where GABA is involved in regulating later stages of postnatal neurogen‐ esis orchestrating synapse formation and dendritic outgrowth. However, although GABA's role in the synaptic integration of postnatally generated neurons is becoming clearer, more work is needed to fully flesh out the internal mechanisms by which GABA activity leads to modulation of actions as disparate as proliferation, migration, synaptic integration, and dendritogenesis.

#### **3.4. Glutamate**

Glutamatehas beenshownto be importantforneuroblast survival,dendriticdevelopment, and synaptogenesis in the developing CNS [105]. In the postnatal SVZ, spontaneous glutamate release from astrocytes onto neuroblasts results in phasic NMDAR activation that increases in frequencyandamplitudeuponmigrationtowards thebulb.Genetic ablationoftheNR1 subunit in migrating neuroblasts results in 60% of these NR1-deficient newborn neurons entering apoptosis, suggesting that NMDAR-dependent glutamatergic signaling is an important factor inregulatingneuroblast survival andnumbers ofnew neurons intheOB[106].Once inthe bulb, newly generated neurons begin to integrate synaptically into the local circuitry, generate action potentialsandfirst establishGABAergic inputs followedbyglutamatergic inputs~4weeks after birth [103]. Recently, newborn granule cells in the OB were shown to express a transient form of LTPinresponse tofocalglutamatergic stimulationinthegranule celllayer.This typeofLTPwas notpresentinmaturegranulecellsandwasobservedincellsbetween2and8weeksold,implying that new neurons have a capacity for synaptic plasticity that is different from their mature counterparts[107].Perhapsthissortofsynapticenhancementcanhelpexplainthepositiveeffects olfactory learning has on SVZ neuroblast survival, as well as the negative effects anti-mitotic activity in the SVZ has on olfactory discrimination.

### **4. Responsiveness and involvement of postnatal neurogenesis in distinct neuropathologies**

#### **4.1. Alzheimer's disease**

**3.3. GABA**

146 Neural Stem Cells - New Perspectives

dendritogenesis.

**3.4. Glutamate**

GABA-mediated depolarization of immature neurons has been shown to be critical for synapse formation in the developing cortex [102]. Postnatally, following migration into the OB SVZ neuroblasts begin the process of integrating into the local circuitry by radially migrating out of the RMS core, elaborating a complex dendritic structure and establishing appropriate synapses [5;103]. A role for GABAA signaling in the initiation, elongation and stabilization of dendritic structures in immature neurons has been established in the OB. Specifically, it was discovered that ambient GABA-induced depolarization and Ca2+-influx was necessary for the stabilization of emerging dendritic protrusions and enhanced the number and length of preexisting dendrites, in SVZ culture as well as OB slice preparations [104]. This effect was specific to the immature neuron population because six days following plating, KCC2 levels had increased sufficiently to block the depolarizing effects of GABA and the modulatory effects of GABA-depolarization on dendrite development. Furthermore, GABA activity promoted initiation and elongation of immature neuroblast dendrites in culture by stabilizing tubulin in its polymerized form. Knockdown of NKCC1 and prevention of GABA-mediated depolari‐ zation in immature neurons also resulted in dendritic morphological deficits. However, this

This regulation by GABA in both the OB and DG helps shape neurogenesis as an activitydependent process where GABA is involved in regulating later stages of postnatal neurogen‐ esis orchestrating synapse formation and dendritic outgrowth. However, although GABA's role in the synaptic integration of postnatally generated neurons is becoming clearer, more work is needed to fully flesh out the internal mechanisms by which GABA activity leads to modulation of actions as disparate as proliferation, migration, synaptic integration, and

Glutamatehas beenshownto be importantforneuroblast survival,dendriticdevelopment, and synaptogenesis in the developing CNS [105]. In the postnatal SVZ, spontaneous glutamate release from astrocytes onto neuroblasts results in phasic NMDAR activation that increases in frequencyandamplitudeuponmigrationtowards thebulb.Genetic ablationoftheNR1 subunit in migrating neuroblasts results in 60% of these NR1-deficient newborn neurons entering apoptosis, suggesting that NMDAR-dependent glutamatergic signaling is an important factor inregulatingneuroblast survival andnumbers ofnew neurons intheOB[106].Once inthe bulb, newly generated neurons begin to integrate synaptically into the local circuitry, generate action potentialsandfirst establishGABAergic inputs followedbyglutamatergic inputs~4weeks after birth [103]. Recently, newborn granule cells in the OB were shown to express a transient form of LTPinresponse tofocalglutamatergic stimulationinthegranule celllayer.This typeofLTPwas notpresentinmaturegranulecellsandwasobservedincellsbetween2and8weeksold,implying that new neurons have a capacity for synaptic plasticity that is different from their mature counterparts[107].Perhapsthissortofsynapticenhancementcanhelpexplainthepositiveeffects olfactory learning has on SVZ neuroblast survival, as well as the negative effects anti-mitotic

effect was transient and dendritiric morphology recovered in adults [80].

activity in the SVZ has on olfactory discrimination.

Alzheimer's disease (AD) is a late-onset neurological disease with a heritable component characterized by deposition of β-amyloid peptides (Aβ), formation of neurofibrillary tangles, reactive astrocytosis, activation of microglial cells and cholinergic deficits [108]. The effect of AD is a progressive neurodegeneration throughout the neocortex and hippocampus, and severe dementia [109]. SVZ neurogenesis is reduced in mouse models of AD and has also been shown to be diminished in postmortem tissue from human AD patients. Mice harboring familial mutations in amyloid precursor protein (APP) and presinilin 1 (PS1) show decreased proliferation in the SVZ [110;111]. Infusion of Aβ peptide into the lateral ventricles also decreases proliferation in the postnatal SVZ [112]. SVZ-derived neural progenitor cells from PS1 mutants and the APPSwe/PS1ΔE9 double-mutants showed decreased cycling *in vitro* [112; 113]. In postmortem tissue, AD patients showed decreased numbers of proliferative (Ki67<sup>+</sup> ) cells in the SVZ [114]. Anosmia or hyposmia, the inability or reduced ability to perceive smell, are predictive indicators of Alzheimer's progression in the clinic. However, it remains to be conclusively established whether altered SVZ neurogenesis is the cause of this disrupted olfaction in AD patients.

#### **4.2. Parkinson's disease**

Parkinson's disease (PD) develops due to the specific loss of dopaminergic neurons in the substantia nigra (SN) and results in impaired regulation of movement, mood, and motivation [69]. In mouse models of PD SVZ proliferation is reduced. This is thought to be due to the loss of dopaminergic inputs to the SVZ from the SN via the nigrostriatal pathway, as chemical ablation of these fibers results in decreased proliferation in the SVZ and decreased numbers of mature granule neurons in the OB [69;74]. This effect on proliferation was partially rescued with the application of the dopamine precursor levodopa. Furthermore, in postmortem tissue from human AD patients SVZ proliferation was reduced, as were numbers of immature neurons in the granule cell layer of the OB [69]. However, increases in numbers of periglo‐ merular dopaminergic neurons have also been reported in mouse models of PD using chemical ablation, and in PD postmortem human tissue [74;115]. Because dopaminergic activity of periglomerular cells generally inhibits the transmission of olfactory information, it is thought that the decreased numbers of granule cells and the increased numbers of periglomerular cells together contribute to the hyposmia and disturbed olfaction seen in PD patients.

#### **4.3. Huntington's disease**

Huntington's disease (HD) is caused by expansions in CAG repeat elements in the gene encoding huntingin. This leads to aggregation of mutant huntingtin and neurodegeneration in the striatum [116]. In mouse models of HD there is little striatal neurodegeneration and consequently SVZ neurogenesis remains unchanged. However, in rat models of striatal degeneration SVZ proliferation is increased [117;118]. Some cells from the SVZ are seen to ectopically migrate into the damaged striatum and begin expressing markers of newborn neurons, although any functional recovery was not reported [118]. In HD patients an increase in proliferation in the SVZ is observed that corresponds with the number of CAG repeats, and SVZ cells are seen to migrate into the damaged striatum where they express both proliferative as well as mature neuronal markers. It remains to be seen whether the expression of both proliferative and mature markers in SVZ-derived cells within the HD-damaged striatum is symptomatic of HD or in fact, can contribute to functional recovery [119-121]. However, the potential for endogenous repair for HD can still be seen as promising, as newborn neurons would take a long time to develop huntingtin inclusions and in the meantime participate in the maintenance of striatal circuitry.

increased immature neurons were also observed [130]. In humans, increases proliferation and ectopic migration have also been observed in organotypic slice preparations [131]. These effects on neurogenesis seem to be symptomatic of epilepsy, whether they can be harnessed as a way

Postnatal Neurogenesis in the Subventricular Zone: A Manipulable Source for CNS Plasticity and Repair

http://dx.doi.org/10.5772/55679

149

It has long been suggested that the SVZ is the source of origin for malignant gliomas. The prognosis for these cancers is very poor and for glioblastoma, the most common variant in adults, the median survival rate is only 9-12 months [132-134]. A few years ago, in a mouse model of malignant astrocytoma that included a p53 deletion and a conditional disruption of the neurofibromatosis type 1 (NF1) gene, researchers conclusively established that the originating tumorigenic mutation arises within the SVZ atrocyte-like stem cell [135]. Recently it was further shown that although the mutation arises in the neural stem cell, the cancer begins at a subsequent stage, when these stem cells have committed to the oligodendrocytic lineage [136]. Studies of the molecular characteristics of low-grade human astrocytomas suggested that most often in these conditions p53 is deleted and Ras signaling is elevated. Since NF1 is a negative regulator of Ras, its deletion would result in increased Ras activity and in conjunction with the p53 deletion more accurately model human astrocytomas. In mice, this genetic strategy produced astrocytomas with complete penetrance, suggesting that NF1 and p53 deletion are sufficient to induce cancer. When tumor development was closely followed in these mice, it was discovered to arise from the SVZ in nearly every instance before dispersing to other brain regions. These results demonstrate that therapeutic intervention utilizing SVZ neurogenesis must guarantee against the elevated risk of tumorigenesis, and that continued research is necessary to manipulate the proliferation, fate choice, migration and differentiation of SVZ progenitors. Perhaps one day a therapy can be conceived to induce cell death in

to treat the damage caused by repeated seizure activity remains to be seen.

progenitors that have become transformed into precancerous cell types.

regions, for directed endogenous circuit repair.

Ithas alsobeenrecentlydemonstratedthat SVZdysfunctioncancontribute tothepathophysiol‐ ogy of neuropsychiatric conditions like tuberous sclerosis complex (TSC). TSC is caused by loss ofeitheroneoftwotumorsuppressorgenes,*TSC1*and*TSC2*,whichencodehamartinandtuberin, respectively. Mutations in these genes lead to hyperactivity of the mammalian target of rapamycin(mTOR)signalingpathway.NeurologicalsymptomsofTSCincludeseizures,autism, psychiatric problems and the presence or subendymal nodules, heterotopias and giant, ectopically localized cells with both neuronal and glial characteristics. A recent study mod‐ eled TSC in mice by conditionally ablating *Tsc1* specifically in the postnatal SVZ. This pro‐ ducedectopicmigrationanddifferentiationofneuronalprecursors,resultinginhetertopiasand micronodules containing neurons with a hypertrophic dendritic tree in aberrant locations. Furthermore, *Tsc1*-mutant cells were shown to be rerouted to forebrain structures where they differentiated into neurons and glia. This remarkable rerouting of SVZ cells to the cortex is thought to be occurring at a very low rate under normal circumstances, but becomes elevated whenmTORactivity ispathogenically increased[137].Itis hypothesizedthatthese ectopic cells inthecortexcontributetonetworkmalfunctioninhigher-ordercognitivefunction.This research also opens up the exciting idea of actively rerouting cells to the cortex, or other desired brain

**4.6. Precancerous lesions and cortical heterotopias**

#### **4.4. Ischemic stroke**

A stroke results from either a hemorrhage or blocked cerebral arteries, leading to diminished local blood flow (ischemia) in a brain region and loss of neurons. In stroked tissue, the core infarcted area is distinguishable from the surrounding penumbral area by the exaggerated necrosis and little potential for regeneration. In the penumbral region on the other hand, neuronal regeneration has been demonstrated as it is perfused by collateral arteries and not wholly dependent on the occluded artery for oxygen. As ischemic stroke is one of the most frequent causes of mortality in industrialized countries, a lot of research has been undertaken to probe the capacity for regeneration in this condition. In rodent and primate models of stroke where the medial cerebral artery is occluded (MCAO), SVZ proliferation and the numbers of neurons in the OB are increased [122-124]. In addition, ectopic neurogenesis is also observed in the penumbral areas, such as the striatum [125]. Some groups have also reported ectopic neurogenesis in cortical regions following stroke (Gu 2000, sun 2003) but this has been denied by others [125]. In the stroked striatum, SVZ-derived cells differentiate into medium spiny GABAergic neurons which represent 90% of striatal neurons and are lost there, although once in the striatum many of the newborn neurons undergo cell death [125]. However, this finding is greatly encouraging for the continued study of an effective neuronal replacement strategy as a means to treat stroke damage in the CNS. As proof of this idea, ablating neurogenesis in mouse models of stroke greatly exacerbated cell death and postischemic sensorimotor deficits, suggesting that neurogenesis can account for some amelioration of stroke-induced damage [126]. In human stroke patients, increased proliferation has been observed in the ipsilateral SVZ and traces of ectopic neurogenesis were seen in the cortex [127-129]. The functional recovery that this observed increase in neurogenesis following stroke is able to accomplish remains to be validated, but it does suggest that some measure of recovery is endogenously possible and may be drawn out with continued research and more-tailored therapeutic intervention.

#### **4.5. Epilepsy**

Epilepsy has also been shown to alter SVZ neurogenesis. In rats, pilocarpine-induced seizures increased SVZ proliferation as well as expanded the extent of the RMS. Ectopic migration and increased immature neurons were also observed [130]. In humans, increases proliferation and ectopic migration have also been observed in organotypic slice preparations [131]. These effects on neurogenesis seem to be symptomatic of epilepsy, whether they can be harnessed as a way to treat the damage caused by repeated seizure activity remains to be seen.

#### **4.6. Precancerous lesions and cortical heterotopias**

degeneration SVZ proliferation is increased [117;118]. Some cells from the SVZ are seen to ectopically migrate into the damaged striatum and begin expressing markers of newborn neurons, although any functional recovery was not reported [118]. In HD patients an increase in proliferation in the SVZ is observed that corresponds with the number of CAG repeats, and SVZ cells are seen to migrate into the damaged striatum where they express both proliferative as well as mature neuronal markers. It remains to be seen whether the expression of both proliferative and mature markers in SVZ-derived cells within the HD-damaged striatum is symptomatic of HD or in fact, can contribute to functional recovery [119-121]. However, the potential for endogenous repair for HD can still be seen as promising, as newborn neurons would take a long time to develop huntingtin inclusions and in the meantime participate in

A stroke results from either a hemorrhage or blocked cerebral arteries, leading to diminished local blood flow (ischemia) in a brain region and loss of neurons. In stroked tissue, the core infarcted area is distinguishable from the surrounding penumbral area by the exaggerated necrosis and little potential for regeneration. In the penumbral region on the other hand, neuronal regeneration has been demonstrated as it is perfused by collateral arteries and not wholly dependent on the occluded artery for oxygen. As ischemic stroke is one of the most frequent causes of mortality in industrialized countries, a lot of research has been undertaken to probe the capacity for regeneration in this condition. In rodent and primate models of stroke where the medial cerebral artery is occluded (MCAO), SVZ proliferation and the numbers of neurons in the OB are increased [122-124]. In addition, ectopic neurogenesis is also observed in the penumbral areas, such as the striatum [125]. Some groups have also reported ectopic neurogenesis in cortical regions following stroke (Gu 2000, sun 2003) but this has been denied by others [125]. In the stroked striatum, SVZ-derived cells differentiate into medium spiny GABAergic neurons which represent 90% of striatal neurons and are lost there, although once in the striatum many of the newborn neurons undergo cell death [125]. However, this finding is greatly encouraging for the continued study of an effective neuronal replacement strategy as a means to treat stroke damage in the CNS. As proof of this idea, ablating neurogenesis in mouse models of stroke greatly exacerbated cell death and postischemic sensorimotor deficits, suggesting that neurogenesis can account for some amelioration of stroke-induced damage [126]. In human stroke patients, increased proliferation has been observed in the ipsilateral SVZ and traces of ectopic neurogenesis were seen in the cortex [127-129]. The functional recovery that this observed increase in neurogenesis following stroke is able to accomplish remains to be validated, but it does suggest that some measure of recovery is endogenously possible and may be drawn out with continued research and more-tailored therapeutic

Epilepsy has also been shown to alter SVZ neurogenesis. In rats, pilocarpine-induced seizures increased SVZ proliferation as well as expanded the extent of the RMS. Ectopic migration and

the maintenance of striatal circuitry.

**4.4. Ischemic stroke**

148 Neural Stem Cells - New Perspectives

intervention.

**4.5. Epilepsy**

It has long been suggested that the SVZ is the source of origin for malignant gliomas. The prognosis for these cancers is very poor and for glioblastoma, the most common variant in adults, the median survival rate is only 9-12 months [132-134]. A few years ago, in a mouse model of malignant astrocytoma that included a p53 deletion and a conditional disruption of the neurofibromatosis type 1 (NF1) gene, researchers conclusively established that the originating tumorigenic mutation arises within the SVZ atrocyte-like stem cell [135]. Recently it was further shown that although the mutation arises in the neural stem cell, the cancer begins at a subsequent stage, when these stem cells have committed to the oligodendrocytic lineage [136]. Studies of the molecular characteristics of low-grade human astrocytomas suggested that most often in these conditions p53 is deleted and Ras signaling is elevated. Since NF1 is a negative regulator of Ras, its deletion would result in increased Ras activity and in conjunction with the p53 deletion more accurately model human astrocytomas. In mice, this genetic strategy produced astrocytomas with complete penetrance, suggesting that NF1 and p53 deletion are sufficient to induce cancer. When tumor development was closely followed in these mice, it was discovered to arise from the SVZ in nearly every instance before dispersing to other brain regions. These results demonstrate that therapeutic intervention utilizing SVZ neurogenesis must guarantee against the elevated risk of tumorigenesis, and that continued research is necessary to manipulate the proliferation, fate choice, migration and differentiation of SVZ progenitors. Perhaps one day a therapy can be conceived to induce cell death in progenitors that have become transformed into precancerous cell types.

Ithas alsobeenrecentlydemonstratedthat SVZdysfunctioncancontribute tothepathophysiol‐ ogy of neuropsychiatric conditions like tuberous sclerosis complex (TSC). TSC is caused by loss ofeitheroneoftwotumorsuppressorgenes,*TSC1*and*TSC2*,whichencodehamartinandtuberin, respectively. Mutations in these genes lead to hyperactivity of the mammalian target of rapamycin(mTOR)signalingpathway.NeurologicalsymptomsofTSCincludeseizures,autism, psychiatric problems and the presence or subendymal nodules, heterotopias and giant, ectopically localized cells with both neuronal and glial characteristics. A recent study mod‐ eled TSC in mice by conditionally ablating *Tsc1* specifically in the postnatal SVZ. This pro‐ ducedectopicmigrationanddifferentiationofneuronalprecursors,resultinginhetertopiasand micronodules containing neurons with a hypertrophic dendritic tree in aberrant locations. Furthermore, *Tsc1*-mutant cells were shown to be rerouted to forebrain structures where they differentiated into neurons and glia. This remarkable rerouting of SVZ cells to the cortex is thought to be occurring at a very low rate under normal circumstances, but becomes elevated whenmTORactivity ispathogenically increased[137].Itis hypothesizedthatthese ectopic cells inthecortexcontributetonetworkmalfunctioninhigher-ordercognitivefunction.This research also opens up the exciting idea of actively rerouting cells to the cortex, or other desired brain regions, for directed endogenous circuit repair.

#### **5. Conclusion**

New neurons continue to be produced throughout life in two regions of the mammalian CNS and a plethora of research has accumulated demonstrating how this amazing propensity for plasticity is orchestrated and regulated. Postnatal SVZ neurogenesis has been shown to make important contributions to coordinated network activity in the OB as well as serving as a sensor for different neurological disease states. But most importantly, it continues to provide tantalizing potentials for a source of endogenous repair within the CNS.

[7] Platel JC, Gordon V, Heintz T, Bordey A. GFAP-GFP neural progenitors are antigeni‐ cally homogeneous and anchored in their enclosed mosaic niche. Glia 2009 Jan

Postnatal Neurogenesis in the Subventricular Zone: A Manipulable Source for CNS Plasticity and Repair

http://dx.doi.org/10.5772/55679

151

[8] Bordey A. Adult neurogenesis: basic concepts of signaling. Cell Cycle 2006 Apr;5(7):

[9] Parras CM, Galli R, Britz O, Soares S, Galichet C, Battiste J, et al. Mash1 specifies neu‐ rons and oligodendrocytes in the postnatal brain. EMBO J 2004 Nov 10;23(22):

[10] Tomita K, Moriyoshi K, Nakanishi S, Guillemot F, Kageyama R. Mammalian achaetescute and atonal homologs regulate neuronal versus glial fate determination in the

[11] Doetsch F, Garcia-Verdugo JM, Alvarez-Buylla A. Cellular composition and three-di‐ mensional organization of the subventricular germinal zone in the adult mammalian

[12] Altman J. Autoradiographic and histological studies of postnatal neurogenesis. IV. Cell proliferation and migration in the anterior forebrain, with special reference to persisting neurogenesis in the olfactory bulb. J Comp Neurol 1969 Dec;137(4):433-57.

[13] Lois C, Alvarez-Buylla A. Long-distance neuronal migration in the adult mammalian

[14] De MS, Fasolo A, Shipley M, Puche A. Unique neuronal tracers show migration and differentiation of SVZ progenitors in organotypic slices. J Neurobiol 2001 Dec;49(4):

[15] Lois C, Garcia-Verdugo JM, Alvarez-Buylla A. Chain migration of neuronal precur‐

[16] Altman J, Das GD. Autoradiographic and histological studies of postnatal neurogen‐ esis. I. A longitudinal investigation of the kinetics, migration and transformation of cells incorporating tritiated thymidine in neonate rats, with special reference to post‐ natal neurogenesis in some brain regions. J Comp Neurol 1966 Mar;126(3):337-89. [17] Hinds JW. Autoradiographic study of histogenesis in the mouse olfactory bulb. I. Time of origin of neurons and neuroglia. J Comp Neurol 1968 Nov;134(3):287-304. [18] Kishi K. Golgi studies on the development of granule cells of the rat olfactory bulb with reference to migration in the subependymal layer. J Comp Neurol 1987 Apr

[19] Brill MS, Ninkovic J, Winpenny E, Hodge RD, Ozen I, Yang R, et al. Adult generation

of glutamatergic olfactory bulb interneurons. Nat Neurosci 2009 Nov 1.

central nervous system. EMBO J 2000 Oct 16;19(20):5460-72.

brain. J Neurosci 1997 Jul 1;17(13):5046-61.

brain. Science 1994 May 20;264(5162):1145-8.

sors. Science 1996 Feb 16;271(5251):978-81.

1;57(1):66-78.

722-8.

4495-505.

326-38.

1;258(1):112-24.

#### **Author details**

Manavendra Pathania and Angelique Bordey\*

\*Address all correspondence to: angelique.bordey@yale.edu

Departments of Neurosurgery, and Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, Connecticut, USA

#### **References**


[7] Platel JC, Gordon V, Heintz T, Bordey A. GFAP-GFP neural progenitors are antigeni‐ cally homogeneous and anchored in their enclosed mosaic niche. Glia 2009 Jan 1;57(1):66-78.

**5. Conclusion**

150 Neural Stem Cells - New Perspectives

**Author details**

**References**

11;97(6):703-16.

7153-60.

Manavendra Pathania and Angelique Bordey\*

School of Medicine, New Haven, Connecticut, USA

\*Address all correspondence to: angelique.bordey@yale.edu

GFAP. J Neurosci 2003 Apr 1;23(7):2824-32.

adult brain. Neuron 2004 Mar 4;41(5):683-6.

New neurons continue to be produced throughout life in two regions of the mammalian CNS and a plethora of research has accumulated demonstrating how this amazing propensity for plasticity is orchestrated and regulated. Postnatal SVZ neurogenesis has been shown to make important contributions to coordinated network activity in the OB as well as serving as a sensor for different neurological disease states. But most importantly, it continues to provide

Departments of Neurosurgery, and Cellular and Molecular Physiology, Yale University

[1] Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, Alvarez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 1999 Jun

[2] Imura T, Kornblum HI, Sofroniew MV. The predominant neural stem cell isolated from postnatal and adult forebrain but not early embryonic forebrain expresses

[3] Seri B, Garcia-Verdugo JM, McEwen BS, Alvarez-Buylla A. Astrocytes give rise to new neurons in the adult mammalian hippocampus. J Neurosci 2001 Sep 15;21(18):

[4] Alvarez-Buylla A, Lim DA. For the long run: maintaining germinal niches in the

[5] Carleton A, Petreanu LT, Lansford R, Alvarez-Buylla A, Lledo PM. Becoming a new

[6] Capela A, Temple S. LeX/ssea-1 is expressed by adult mouse CNS stem cells, identi‐

neuron in the adult olfactory bulb. Nat Neurosci 2003 May;6(5):507-18.

fying them as nonependymal. Neuron 2002 Aug 29;35(5):865-75.

tantalizing potentials for a source of endogenous repair within the CNS.


[20] Kosaka K, Toida K, Aika Y, Kosaka T. How simple is the organization of the olfacto‐ ry glomerulus?: the heterogeneity of so-called periglomerular cells. Neurosci Res 1998 Feb;30(2):101-10.

[32] Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995 May

Postnatal Neurogenesis in the Subventricular Zone: A Manipulable Source for CNS Plasticity and Repair

http://dx.doi.org/10.5772/55679

153

[33] Yoshikawa K. Cell cycle regulators in neural stem cells and postmitotic neurons.

[34] Gil-Perotin S, Marin-Husstege M, Li J, Soriano-Navarro M, Zindy F, Roussel MF, et al. Loss of p53 induces changes in the behavior of subventricular zone cells: implica‐

[35] Hornstein E, Shomron N. Canalization of development by microRNAs. Nat Genet

[36] Giraldez AJ, Cinalli RM, Glasner ME, Enright AJ, Thomson JM, Baskerville S, et al. MicroRNAs regulate brain morphogenesis in zebrafish. Science 2005 May

[37] Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, Kiebler M, et al. A brainspecific microRNA regulates dendritic spine development. Nature 2006 Jan

[38] Cheng LC, Pastrana E, Tavazoie M, Doetsch F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci 2009 Apr;12(4):399-408. [39] Visvanathan J, Lee S, Lee B, Lee JW, Lee SK. The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. Genes Dev

[40] Conaco C, Otto S, Han JJ, Mandel G. Reciprocal actions of REST and a microRNA promote neuronal identity. Proc Natl Acad Sci U S A 2006 Feb 14;103(7):2422-7. [41] Makeyev EV, Zhang J, Carrasco MA, Maniatis T. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing.

[42] Boutz PL, Stoilov P, Li Q, Lin CH, Chawla G, Ostrow K, et al. A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative

[43] Mudo G, Bonomo A, Di L, V, Frinchi M, Fuxe K, Belluardo N. The FGF-2/FGFRs neu‐ rotrophic system promotes neurogenesis in the adult brain. J Neural Transm 2009

[44] Wagner JP, Black IB, DiCicco-Bloom E. Stimulation of neonatal and adult brain neu‐ rogenesis by subcutaneous injection of basic fibroblast growth factor. J Neurosci 1999

[45] Kuhn HG, Winkler J, Kempermann G, Thal LJ, Gage FH. Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the

splicing in developing neurons. Genes Dev 2007 Jul 1;21(13):1636-52.

adult rat brain. J Neurosci 1997 Aug 1;17(15):5820-9.

tion for the genesis of glial tumors. J Neurosci 2006 Jan 25;26(4):1107-16.

5;81(3):323-30.

Neurosci Res 2000 May;37(1):1-14.

2006 Jun;38 Suppl:S20-S24.

6;308(5723):833-8.

19;439(7074):283-9.

2007 Apr 1;21(7):744-9.

Aug;116(8):995-1005.

Jul 15;19(14):6006-16.

Mol Cell 2007 Aug 3;27(3):435-48.


[32] Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995 May 5;81(3):323-30.

[20] Kosaka K, Toida K, Aika Y, Kosaka T. How simple is the organization of the olfacto‐ ry glomerulus?: the heterogeneity of so-called periglomerular cells. Neurosci Res

[21] Lledo PM, Alonso M, Grubb MS. Adult neurogenesis and functional plasticity in

[22] Kosaka T, Hataguchi Y, Hama K, Nagatsu I, Wu JY. Coexistence of immunoreactivi‐ ties for glutamate decarboxylase and tyrosine hydroxylase in some neurons in the periglomerular region of the rat main olfactory bulb: possible coexistence of gammaaminobutyric acid (GABA) and dopamine. Brain Res 1985 Sep 16;343(1):166-71. [23] Kosaka K, Kosaka T. synaptic organization of the glomerulus in the main olfactory bulb: compartments of the glomerulus and heterogeneity of the periglomerular cells.

[24] Roybon L, Deierborg T, Brundin P, Li JY. Involvement of Ngn2, Tbr and NeuroD proteins during postnatal olfactory bulb neurogenesis. Eur J Neurosci 2009 Jan;29(2):

[25] Farah MH, Olson JM, Sucic HB, Hume RI, Tapscott SJ, Turner DL. Generation of neu‐ rons by transient expression of neural bHLH proteins in mammalian cells. Develop‐

[26] Roybon L, Mastracci TL, Ribeiro D, Sussel L, Brundin P, Li JY. GABAergic Differen‐ tiation Induced by Mash1 Is Compromised by the bHLH Proteins Neurogenin2,

[27] Petrik D, Jiang Y, Birnbaum SG, Powell CM, Kim MS, Hsieh J, et al. Functional and mechanistic exploration of an adult neurogenesis-promoting small molecule. FASEB

[28] Bally-Cuif L, Hammerschmidt M. Induction and patterning of neuronal develop‐ ment, and its connection to cell cycle control. Curr Opin Neurobiol 2003 Feb;13(1):

[29] Doetsch F, Verdugo JM, Caille I, Alvarez-Buylla A, Chao MV, Casaccia-Bonnefil P. Lack of the cell-cycle inhibitor p27Kip1 results in selective increase of transit-ampli‐

[30] Coskun V, Luskin MB. The expression pattern of the cell cycle inhibitor p19(INK4d) by progenitor cells of the rat embryonic telencephalon and neonatal anterior subven‐

[31] Zindy F, Cunningham JJ, Sherr CJ, Jogal S, Smeyne RJ, Roussel MF. Postnatal neuro‐ nal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kin‐

fying cells for adult neurogenesis. J Neurosci 2002 Mar 15;22(6):2255-64.

neuronal circuits. Nat Rev Neurosci 2006 Mar;7(3):179-93.

1998 Feb;30(2):101-10.

152 Neural Stem Cells - New Perspectives

Anat Sci Int 2005 Jun;80(2):80-90.

ment 2000 Feb;127(4):693-702.

J 2012 Aug;26(8):3148-62.

NeuroD1, and NeuroD2. Cereb Cortex 2009 Sep 18.

tricular zone. J Neurosci 2001 May 1;21(9):3092-103.

ases. Proc Natl Acad Sci U S A 1999 Nov 9;96(23):13462-7.

232-43.

16-25.


[46] Jin K, Sun Y, Xie L, Batteur S, Mao XO, Smelick C, et al. Neurogenesis and aging: FGF-2 and HB-EGF restore neurogenesis in hippocampus and subventricular zone of aged mice. Aging Cell 2003 Jun;2(3):175-83.

[58] Lange C, Mix E, Frahm J, Glass A, Muller J, Schmitt O, et al. Small molecule GSK-3 inhibitors increase neurogenesis of human neural progenitor cells. Neurosci Lett 2011

Postnatal Neurogenesis in the Subventricular Zone: A Manipulable Source for CNS Plasticity and Repair

http://dx.doi.org/10.5772/55679

155

[59] Wu W, Wong K, Chen J, Jiang Z, Dupuis S, Wu JY, et al. Directional guidance of neu‐ ronal migration in the olfactory system by the protein Slit. Nature 1999 Jul

[60] Murase S, Horwitz AF. Deleted in colorectal carcinoma and differentially expressed integrins mediate the directional migration of neural precursors in the rostral migra‐

[61] Nguyen-Ba-Charvet KT, Picard-Riera N, Tessier-Lavigne M, Baron-Van EA, Sotelo C, Chedotal A. Multiple roles for slits in the control of cell migration in the rostral mi‐

[62] Ng KL, Li JD, Cheng MY, Leslie FM, Lee AG, Zhou QY. Dependence of olfactory bulb neurogenesis on prokineticin 2 signaling. Science 2005 Jun 24;308(5730):1923-7.

[63] Conover JC, Doetsch F, Garcia-Verdugo JM, Gale NW, Yancopoulos GD, Alvarez-Buylla A. Disruption of Eph/ephrin signaling affects migration and proliferation in

[64] Holmberg J, Armulik A, Senti KA, Edoff K, Spalding K, Momma S, et al. Ephrin-A2 reverse signaling negatively regulates neural progenitor proliferation and neurogen‐

[65] Emsley JG, Hagg T. alpha6beta1 integrin directs migration of neuronal precursors in

[66] Saghatelyan A, de CA, Schachner M, Lledo PM. Tenascin-R mediates activity-de‐ pendent recruitment of neuroblasts in the adult mouse forebrain. Nat Neurosci 2004

[67] Hack I, Bancila M, Loulier K, Carroll P, Cremer H. Reelin is a detachment signal in tangential chain-migration during postnatal neurogenesis. Nat Neurosci 2002 Oct;

[68] Hagg T. Molecular regulation of adult CNS neurogenesis: an integrated view. Trends

[69] Hoglinger GU, Rizk P, Muriel MP, Duyckaerts C, Oertel WH, Caille I, et al. Dopa‐ mine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neuro‐

[70] Miller FD, Gauthier-Fisher A. Home at last: neural stem cell niches defined. Cell

the adult subventricular zone. Nat Neurosci 2000 Nov;3(11):1091-7.

adult mouse forebrain. Exp Neurol 2003 Oct;183(2):273-85.

tory stream. J Neurosci 2002 May 1;22(9):3568-79.

esis. Genes Dev 2005 Feb 15;19(4):462-71.

Neurosci 2005 Nov;28(11):589-95.

Stem Cell 2009 Jun 5;4(6):507-10.

sci 2004 Jul;7(7):726-35.

gratory stream. J Neurosci 2004 Feb 11;24(6):1497-506.

Jan 13;488(1):36-40.

22;400(6742):331-6.

Apr;7(4):347-56.

5(10):939-45.


[58] Lange C, Mix E, Frahm J, Glass A, Muller J, Schmitt O, et al. Small molecule GSK-3 inhibitors increase neurogenesis of human neural progenitor cells. Neurosci Lett 2011 Jan 13;488(1):36-40.

[46] Jin K, Sun Y, Xie L, Batteur S, Mao XO, Smelick C, et al. Neurogenesis and aging: FGF-2 and HB-EGF restore neurogenesis in hippocampus and subventricular zone of

[47] Jin K, Xie L, Childs J, Sun Y, Mao XO, Logvinova A, et al. Cerebral neurogenesis is induced by intranasal administration of growth factors. Ann Neurol 2003 Mar;53(3):

[48] Lillien L, Raphael H. BMP and FGF regulate the development of EGF-responsive

[49] Burrows RC, Wancio D, Levitt P, Lillien L. Response diversity and the timing of pro‐ genitor cell maturation are regulated by developmental changes in EGFR expression

[50] Doetsch F, Petreanu L, Caille I, Garcia-Verdugo JM, Alvarez-Buylla A. EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem

[51] Hurtado-Chong A, Yusta-Boyo MJ, Vergano-Vera E, Bulfone A, de PF, Vicario-Abe‐ jon C. IGF-I promotes neuronal migration and positioning in the olfactory bulb and the exit of neuroblasts from the subventricular zone. Eur J Neurosci 2009 Sep;30(5):

[52] Jin K, Zhu Y, Sun Y, Mao XO, Xie L, Greenberg DA. Vascular endothelial growth fac‐ tor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci U S A

[53] Balordi F, Fishell G. Mosaic removal of hedgehog signaling in the adult SVZ reveals that the residual wild-type stem cells have a limited capacity for self-renewal. J Neu‐

[54] Chambers CB, Peng Y, Nguyen H, Gaiano N, Fishell G, Nye JS. Spatiotemporal selec‐ tivity of response to Notch1 signals in mammalian forebrain precursors. Develop‐

[55] Carlen M, Meletis K, Goritz C, Darsalia V, Evergren E, Tanigaki K, et al. Forebrain ependymal cells are Notch-dependent and generate neuroblasts and astrocytes after

[56] Lim DA, Tramontin AD, Trevejo JM, Herrera DG, Garcia-Verdugo JM, Alvarez-Buyl‐ la A. Noggin antagonizes BMP signaling to create a niche for adult neurogenesis.

[57] Colak D, Mori T, Brill MS, Pfeifer A, Falk S, Deng C, et al. Adult neurogenesis re‐ quires Smad4-mediated bone morphogenic protein signaling in stem cells. J Neurosci

neural progenitor cells. Development 2000 Nov;127(22):4993-5005.

aged mice. Aging Cell 2003 Jun;2(3):175-83.

in the cortex. Neuron 1997 Aug;19(2):251-67.

cells. Neuron 2002 Dec 19;36(6):1021-34.

2002 Sep 3;99(18):11946-50.

rosci 2007 Dec 26;27(52):14248-59.

ment 2001 Mar;128(5):689-702.

Neuron 2000 Dec;28(3):713-26.

2008 Jan 9;28(2):434-46.

stroke. Nat Neurosci 2009 Mar;12(3):259-67.

405-9.

154 Neural Stem Cells - New Perspectives

742-55.


[71] Kim Y, Wang WZ, Comte I, Pastrana E, Tran PB, Brown J, et al. Dopamine stimula‐ tion of postnatal murine subventricular zone neurogenesis via the D3 receptor. J Neurochem 2010 Aug;114(3):750-60.

[84] Wang DD, Krueger DD, Bordey A. GABA depolarizes neuronal progenitors of the postnatal subventricular zone via GABAA receptor activation. J Physiol 2003 Aug

Postnatal Neurogenesis in the Subventricular Zone: A Manipulable Source for CNS Plasticity and Repair

http://dx.doi.org/10.5772/55679

157

[85] Nguyen L, Malgrange B, Breuskin I, Bettendorff L, Moonen G, Belachew S, et al. Au‐ tocrine/paracrine activation of the GABA(A) receptor inhibits the proliferation of neurogenic polysialylated neural cell adhesion molecule-positive (PSA-NCAM+) pre‐

[86] Liu X, Wang Q, Haydar TF, Bordey A. Nonsynaptic GABA signaling in postnatal subventricular zone controls proliferation of GFAP-expressing progenitors. Nat Neu‐

[87] Bolteus AJ, Bordey A. GABA release and uptake regulate neuronal precursor migra‐ tion in the postnatal subventricular zone. J Neurosci 2004 Sep 1;24(35):7623-31.

[88] LoTurco JJ, Owens DF, Heath MJ, Davis MB, Kriegstein AR. GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis. Neuron 1995 Dec;

[89] Haydar TF, Wang F, Schwartz ML, Rakic P. Differential modulation of proliferation in the neocortical ventricular and subventricular zones. J Neurosci 2000 Aug 1;20(15):

[90] Behar TN, Li YX, Tran HT, Ma W, Dunlap V, Scott C, et al. GABA stimulates chemo‐ taxis and chemokinesis of embryonic cortical neurons via calcium-dependent mecha‐

[91] Cameron HA, Hazel TG, McKay RD. Regulation of neurogenesis by growth factors

[92] Schlett K. Glutamate as a modulator of embryonic and adult neurogenesis. Curr Top

[93] Komuro H, Rakic P. Modulation of neuronal migration by NMDA receptors. Science

[94] Di GG, V, Caruso A, Cappuccio I, Ricci VL, Romeo S, Della RC, et al. The mGlu5 me‐ tabotropic glutamate receptor is expressed in zones of active neurogenesis of the em‐ bryonic and postnatal brain. Brain Res Dev Brain Res 2004 May 19;150(1):17-22.

[95] Platel JC, Dave KA, Bordey A. Control of neuroblast production and migration by converging GABA and glutamate signals in the postnatal forebrain. J Physiol 2008

[96] Platel JC, Dave KA, Gordon V, Lacar B, Rubio ME, Bordey A. NMDA receptors acti‐ vated by subventricular zone astrocytic glutamate are critical for neuroblast survival

prior to entering a synaptic network. Neuron 2010 Mar 25;65(6):859-72.

cursor cells from postnatal striatum. J Neurosci 2003 Apr 15;23(8):3278-94.

1;550(Pt 3):785-800.

rosci 2005 Sep;8(9):1179-87.

nisms. J Neurosci 1996 Mar 1;16(5):1808-18.

Med Chem 2006;6(10):949-60.

1993 Apr 2;260(5104):95-7.

Aug 15;586(16):3739-43.

and neurotransmitters. J Neurobiol 1998 Aug;36(2):287-306.

15(6):1287-98.

5764-74.


[84] Wang DD, Krueger DD, Bordey A. GABA depolarizes neuronal progenitors of the postnatal subventricular zone via GABAA receptor activation. J Physiol 2003 Aug 1;550(Pt 3):785-800.

[71] Kim Y, Wang WZ, Comte I, Pastrana E, Tran PB, Brown J, et al. Dopamine stimula‐ tion of postnatal murine subventricular zone neurogenesis via the D3 receptor. J

[72] O'Keeffe GC, Tyers P, Aarsland D, Dalley JW, Barker RA, Caldwell MA. Dopamineinduced proliferation of adult neural precursor cells in the mammalian subventricu‐ lar zone is mediated through EGF. Proc Natl Acad Sci U S A 2009 May 26;106(21):

[73] Yang P, Arnold SA, Habas A, Hetman M, Hagg T. Ciliary neurotrophic factor medi‐ ates dopamine D2 receptor-induced CNS neurogenesis in adult mice. J Neurosci 2008

[74] Winner B, Geyer M, Couillard-Despres S, Aigner R, Bogdahn U, Aigner L, et al. Stria‐ tal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb.

[75] Barker JL, Behar T, Li YX, Liu QY, Ma W, Maric D, et al. GABAergic cells and signals

[76] Owens DF, Kriegstein AR. Is there more to GABA than synaptic inhibition? Nat Rev

[77] Ben Ari Y. Excitatory actions of gaba during development: the nature of the nurture.

[78] Marty A, Llano I. Excitatory effects of GABA in established brain networks. Trends

[79] Mejia-Gervacio S, Murray K, Lledo PM. NKCC1 controls GABAergic signaling and

[80] Young SZ, Taylor MM, Wu S, Ikeda-Matsuo Y, Kubera C, Bordey A. NKCC1 knock‐ down decreases neuron production through GABA(A)-regulated neural progenitor proliferation and delays dendrite development. J Neurosci 2012 Sep 26;32(39):

[81] Ge S, Pradhan DA, Ming GL, Song H. GABA sets the tempo for activity-dependent

[82] Esposito MS, Piatti VC, Laplagne DA, Morgenstern NA, Ferrari CC, Pitossi FJ, et al. Neuronal differentiation in the adult hippocampus recapitulates embryonic develop‐

[83] Wang DD, Krueger DD, Bordey A. Biophysical properties and ionic signature of neu‐ ronal progenitors of the postnatal subventricular zone in situ. J Neurophysiol 2003

neuroblast migration in the postnatal forebrain. Neural Dev 2011;6:4.

adult neurogenesis. Trends Neurosci 2007 Jan;30(1):1-8.

ment. J Neurosci 2005 Nov 2;25(44):10074-86.

in CNS development. Perspect Dev Neurobiol 1998;5(2-3):305-22.

Neurochem 2010 Aug;114(3):750-60.

Exp Neurol 2006 Jan;197(1):113-21.

Neurosci 2002 Sep;3(9):715-27.

Neurosci 2005 Jun;28(6):284-9.

13630-8.

Oct;90(4):2291-302.

Nat Rev Neurosci 2002 Sep;3(9):728-39.

8754-9.

156 Neural Stem Cells - New Perspectives

Feb 27;28(9):2231-41.


[97] Platel JC, Heintz T, Young S, Gordon V, Bordey A. Tonic activation of GLUK5 kai‐ nate receptors decreases neuroblast migration in whole-mounts of the subventricular zone. J Physiol 2008 Aug 15;586(16):3783-93.

[109] Wenk GL. Neuropathologic changes in Alzheimer's disease. J Clin Psychiatry 2003;64

Postnatal Neurogenesis in the Subventricular Zone: A Manipulable Source for CNS Plasticity and Repair

http://dx.doi.org/10.5772/55679

159

[110] Haughey NJ, Nath A, Chan SL, Borchard AC, Rao MS, Mattson MP. Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeo‐

stasis, in models of Alzheimer's disease. J Neurochem 2002 Dec;83(6):1509-24.

[111] Rodriguez JJ, Jones VC, Verkhratsky A. Impaired cell proliferation in the subventric‐ ular zone in an Alzheimer's disease model. Neuroreport 2009 Jul 1;20(10):907-12.

[112] Veeraraghavalu K, Choi SH, Sisodia SS. Expression of familial Alzheimer's diseaselinked human presenilin 1 variants impair enrichment-induced adult hippocampal

[113] Demars M, Hu YS, Gadadhar A, Lazarov O. Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice. J Neurosci Res 2010

[114] Ziabreva I, Perry E, Perry R, Minger SL, Ekonomou A, Przyborski S, et al. Altered neurogenesis in Alzheimer's disease. J Psychosom Res 2006 Sep;61(3):311-6.

[115] Huisman E, Uylings HB, Hoogland PV. A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease. Mov Disord 2004 Jun;

[116] Curtis MA, Eriksson PS, Faull RL. Progenitor cells and adult neurogenesis in neuro‐ degenerative diseases and injuries of the basal ganglia. Clin Exp Pharmacol Physiol

[117] Curtis MA, Eriksson PS, Faull RL. Progenitor cells and adult neurogenesis in neuro‐ degenerative diseases and injuries of the basal ganglia. Clin Exp Pharmacol Physiol

[118] Tattersfield AS, Croon RJ, Liu YW, Kells AP, Faull RL, Connor B. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease. Neuro‐

[119] Curtis MA, Penney EB, Pearson AG, van Roon-Mom WM, Butterworth NJ, Dragu‐ now M, et al. Increased cell proliferation and neurogenesis in the adult human Hun‐

[120] Curtis MA, Penney EB, Pearson J, Dragunow M, Connor B, Faull RL. The distribution of progenitor cells in the subependymal layer of the lateral ventricle in the normal

[121] Curtis MA, Waldvogel HJ, Synek B, Faull RL. A histochemical and immunohisto‐ chemical analysis of the subependymal layer in the normal and Huntington's disease

tington's disease brain. Proc Natl Acad Sci U S A 2003 Jul 22;100(15):9023-7.

and Huntington's disease human brain. Neuroscience 2005;132(3):777-88.

brain. J Chem Neuroanat 2005 Jul;30(1):55-66.

neurogenesis. Neurodegener Dis 2010;7(1-3):46-9.

Suppl 9:7-10.

Aug 1;88(10):2103-17.

2007 May;34(5-6):528-32.

2007 May;34(5-6):528-32.

science 2004;127(2):319-32.

19(6):687-92.


[109] Wenk GL. Neuropathologic changes in Alzheimer's disease. J Clin Psychiatry 2003;64 Suppl 9:7-10.

[97] Platel JC, Heintz T, Young S, Gordon V, Bordey A. Tonic activation of GLUK5 kai‐ nate receptors decreases neuroblast migration in whole-mounts of the subventricular

[98] Giorgi-Gerevini V, Melchiorri D, Battaglia G, Ricci-Vitiani L, Ciceroni C, Busceti CL, et al. Endogenous activation of metabotropic glutamate receptors supports the prolif‐ eration and survival of neural progenitor cells. Cell Death Differ 2005 Aug;12(8):

[99] Giachino C, De Marchis S, Giampietro C, Parlato R, Perroteau I, Schutz G, et al. cAMP response element-binding protein regulates differentiation and survival of newborn neurons in the olfactory bulb. J Neurosci 2005 Nov 2;25(44):10105-18. [100] Pathania M, Platel J-CJ, Teng Z-Q, Zhao X, Bordey A. A role for microRNA-132 in the postnatal subventricular zone and neurogenesis. Program No.531.2009 International Society for Stem Cell Research 7th Annual Meeting Poster Abstracts.Barcelona,

Spain: International Society for Stem Cell Research, 2009.Online. 2009.

[101] Bath KG, Mandairon N, Jing D, Rajagopal R, Kapoor R, Chen ZY, et al. Variant brainderived neurotrophic factor (Val66Met) alters adult olfactory bulb neurogenesis and

[102] Wang DD, Kriegstein AR. GABA regulates excitatory synapse formation in the neo‐ cortex via NMDA receptor activation. J Neurosci 2008 May 21;28(21):5547-58. [103] Belluzzi O, Benedusi M, Ackman J, LoTurco JJ. Electrophysiological differentiation of new neurons in the olfactory bulb. J Neurosci 2003 Nov 12;23(32):10411-8.

[104] Gascon E, Dayer AG, Sauvain MO, Potter G, Jenny B, De Roo M, et al. GABA regu‐ lates dendritic growth by stabilizing lamellipodia in newly generated interneurons of

[105] Nguyen L, Rigo JM, Rocher V, Belachew S, Malgrange B, Rogister B, et al. Neuro‐ transmitters as early signals for central nervous system development. Cell Tissue Res

[106] Platel J-CJ, Dave K, Gordon V, Lacar B, Bordey A. NMDA-receptors are critical for SVZ postnatal neurogenesis. Program No.30.16/B21.2009 Neuroscience Meeting Plan‐

[107] Nissant A, Bardy C, Katagiri H, Murray K, Lledo PM. Adult neurogenesis promotes synaptic plasticity in the olfactory bulb. Nat Neurosci 2009 Jun;12(6):728-30.

[108] Savonenko A, Xu GM, Melnikova T, Morton JL, Gonzales V, Wong MP, et al. Episo‐ dic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's dis‐ ease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.

the olfactory bulb. J Neurosci 2006 Dec 13;26(50):12956-66.

ner.Chicago, IL: Society for Neuroscience, 2009.Online. 2009.

2001 Aug;305(2):187-202.

Neurobiol Dis 2005 Apr;18(3):602-17.

spontaneous olfactory discrimination. J Neurosci 2008 Mar 5;28(10):2383-93.

zone. J Physiol 2008 Aug 15;586(16):3783-93.

1124-33.

158 Neural Stem Cells - New Perspectives


[122] Jin K, Minami M, Lan JQ, Mao XO, Batteur S, Simon RP, et al. Neurogenesis in den‐ tate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc Natl Acad Sci U S A 2001 Apr 10;98(8):4710-5.

[136] Liu C, Sage JC, Miller MR, Verhaak RG, Hippenmeyer S, Vogel H, et al. Mosaic anal‐ ysis with double markers reveals tumor cell of origin in glioma. Cell 2011 Jul

Postnatal Neurogenesis in the Subventricular Zone: A Manipulable Source for CNS Plasticity and Repair

http://dx.doi.org/10.5772/55679

161

[137] Feliciano DM, Bordey A. Newborn cortical neurons: only for neonates? Trends Neu‐

22;146(2):209-21.

rosci 2012 Oct 10.


[136] Liu C, Sage JC, Miller MR, Verhaak RG, Hippenmeyer S, Vogel H, et al. Mosaic anal‐ ysis with double markers reveals tumor cell of origin in glioma. Cell 2011 Jul 22;146(2):209-21.

[122] Jin K, Minami M, Lan JQ, Mao XO, Batteur S, Simon RP, et al. Neurogenesis in den‐ tate subgranular zone and rostral subventricular zone after focal cerebral ischemia in

[123] Zhang R, Zhang L, Zhang Z, Wang Y, Lu M, Lapointe M, et al. A nitric oxide donor induces neurogenesis and reduces functional deficits after stroke in rats. Ann Neurol

[124] Koketsu D, Furuichi Y, Maeda M, Matsuoka N, Miyamoto Y, Hisatsune T. Increased number of new neurons in the olfactory bulb and hippocampus of adult non-human

[125] Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 2002 Sep;8(9):963-70.

[126] Jin K, Wang X, Xie L, Mao XO, Greenberg DA. Transgenic ablation of doublecortinexpressing cells suppresses adult neurogenesis and worsens stroke outcome in mice.

[127] Marti-Fabregas J, Romaguera-Ros M, Gomez-Pinedo U, Martinez-Ramirez S, Jime‐ nez-Xarrie E, Marin R, et al. Proliferation in the human ipsilateral subventricular

[128] Jin K, Wang X, Xie L, Mao XO, Zhu W, Wang Y, et al. Evidence for stroke-induced neurogenesis in the human brain. Proc Natl Acad Sci U S A 2006 Aug 29;103(35):

[129] Macas J, Nern C, Plate KH, Momma S. Increased generation of neuronal progenitors after ischemic injury in the aged adult human forebrain. J Neurosci 2006 Dec

[130] Parent JM, Valentin VV, Lowenstein DH. Prolonged seizures increase proliferating neuroblasts in the adult rat subventricular zone-olfactory bulb pathway. J Neurosci

[131] Gonzalez-Martinez JA, Bingaman WE, Toms SA, Najm IM. Neurogenesis in the post‐

[132] Lantos PL, Cox DJ. The origin of experimental brain tumours: a sequential study. Ex‐

[133] Vick NA, Lin MJ, Bigner DD. The role of the subependymal plate in glial tumorigen‐

[134] Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. N

[135] Zhu Y, Guignard F, Zhao D, Liu L, Burns DK, Mason RP, et al. Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocyto‐

natal human epileptic brain. J Neurosurg 2007 Sep;107(3):628-35.

primates after focal ischemia. Exp Neurol 2006 May;199(1):92-102.

Proc Natl Acad Sci U S A 2010 Apr 27;107(17):7993-8.

zone after ischemic stroke. Neurology 2010 Feb 2;74(5):357-65.

the rat. Proc Natl Acad Sci U S A 2001 Apr 10;98(8):4710-5.

2001 Nov;50(5):602-11.

160 Neural Stem Cells - New Perspectives

13198-202.

13;26(50):13114-9.

2002 Apr 15;22(8):3174-88.

perientia 1976 Nov 15;32(11):1467-8.

Engl J Med 2005 Aug 25;353(8):811-22.

ma. Cancer Cell 2005 Aug;8(2):119-30.

esis. Acta Neuropathol 1977 Sep 26;40(1):63-71.

[137] Feliciano DM, Bordey A. Newborn cortical neurons: only for neonates? Trends Neu‐ rosci 2012 Oct 10.

**Chapter 7**

**Modulation of Adult Neurogenesis by**

**the Nitric Oxide System**

Bruno P. Carreira, Ana I. Santos,

http://dx.doi.org/10.5772/54982

**1. Introduction**

Caetana M. Carvalho and Inês M. Araújo

Additional information is available at the end of the chapter

control different functions of NO (reviewed by [1]).

Nitric oxide (NO) is a gaseous free radical that acts as a second messenger having an important biological role in intercellular communication and in intracellular signaling in many tissues, including the brain (reviewed by [1]). NO is synthesized by the nitric oxide synthase (NOS) family of enzymes, which convert L-arginine to L-citrulline and NO. There are three different isoforms of NOS: a) neuronal NOS (nNOS or NOS I), b) endothelial NOS (eNOS or NOS III), and c) inducible NOS (iNOS or NOS II) (reviewed by [2]). Different members of the NOS family

In the central nervous system (CNS), NO has been linked to the regulation of synaptic plasticity and cognitive functions, and it is also associated with the control of biological functions including sleep-wake cycle, appetite, body temperature, and modulation of hor‐ mone release as reviewed by [3]. In the last decade, there has been a growing interest in the study of the role of NO in neurogenesis, the process by which new neurons are formed in the brain. NO regulates neurogenesis in diverse ways, and the different NO synthases are important players in the different effects on neurogenesis. Under physio‐ logical conditions NO synthesized from nNOS acts as a negative regulator of neurogene‐ sis [4-9], while in inflammatory conditions, such as neurodegenerative disorders or acute brain insults, a decrease in nNOS and an increase in iNOS expression may act as a mechanism to enhance neurogenesis [8,10-13]. In fact, depending on the source, NO has a pro-neurogenic effect either by promoting neural stem cell (NSC) proliferation, as re‐ cently described by our group [13,14], but also by favoring other steps of neurogenesis such as migration [15], differentiation and survival [10,16]. Although the exact molecular mechanisms underlying this dual effect of NO on neurogenesis are not fully clarified, the

> © 2013 Carreira et al.; licensee InTech. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

and reproduction in any medium, provided the original work is properly cited.

© 2013 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,

**Chapter 7**
